Viral haemorrhagic fevers, not elsewhere classified/unspecified

AB1_VIRAL_HEMOR_FEVER_NOS_WIDE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Primary healthcare outpatient: ICD-10 — A98, A99 Hospital discharge: ICD-10 — A98, A99 Hospital discharge: ICD-9 — 06[6] Hospital discharge: ICD-8 — 06[7] Cause of death: ICD-10 — A98, A99 Cause of death: ICD-9 — 06[6] Cause of death: ICD-8 — 06[7] 3 out of 7 registries used, show all original rules.	7027
4. Check minimum number of events None	7027
5. Include endpoints None	7027
6. Filter based on genotype QC (FinnGen only)	6760

Control definitions (FinnGen only)

Control exclude: AB1_ARTHROPOD

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF13

NAME	AB1_VIRAL_HEMOR_FEVER_NOS_WIDE
CONTROL_EXCLUDE	AB1_ARTHROPOD
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD	A9[8-9]
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	A9[8-9]
HD_ICD_9	06[6]
HD_ICD_8	06[7]
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	A9[8-9]
COD_ICD_9	06[6]
COD_ICD_8	06[7]
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Viral haemorrhagic fevers, not elsewhere classified/unspecified based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	6760	3651	3109
Unadjusted period prevalence (%)	1.35	1.30	1.42
Median age at first event (years)	55.88	54.05	58.02

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
7025: Matched controls
70199

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

SPAT1336

SPAT

Request for examination

7.8

307.7

737

1043

A98

ICD-10 Finland

Other viral haemorrhagic fevers, not elsewhere classified

+∞

307.7

3149

A98.5

ICD-10 Finland

Haemorrhagic fever with renal syndrome

+∞

307.7

3805

R50.9

ICD-10 Finland

Fever, unspecified

2.8

238.0

1510

6330

A60

ICPC

General and Unspecified, Result test/procedure

4.6

233.5

582

1339

EB1SA, ,

SPAT

4.1

229.8

681

1789

B60

ICPC

Blood and Immunity, Result test/procedure

10.6

228.8

253

246

SPAT1212

SPAT

Extensive examination of musculoskeletal system

3.4

211.8

849

2731

A48

ICPC

General and Unspecified, Clarification/discussion RFE/demand

3.7

207.5

730

2157

WX110, ,

SPAT

3.6

192.5

694

2081

L28

ICPC

Limited function/disability (L)

2.5

188.1

1503

6968

EB1AA, ,

SPAT

3.3

182.3

737

2375

T45

ICPC

Metabolic, Observ/health educat/advice/diet

7.4

174.2

258

362

W78

ICD-10 Finland

Inhalation of gastric contents

34.2

154.5

A62

ICPC

General and Unspecified, Administrative procedure

4.9

150.2

338

711

D62

ICPC

Digestive, Administrative procedure

15.1

148.5

131

A03

ICPC

Fever

2.2

142.7

1475

7540

QAE99, ,

SPAT

9.6

141.1

167

178

L48

ICPC

Musculoskeletal, Clarification/discussion RFE/demand

8.4

138.8

183

224

K43

ICPC

Cardiovascular, Other diagnostic procedure

8.1

133.2

180

227

EBA00, ,

SPAT

4.3

130.2

344

823

Z2221

NOMESCO Finland

Medical doctor

1.9

129.0

2119

12770

L17, ,

ICD-10 Finland

20.3

128.2

K48

ICPC

Cardiovascular, Clarification/discussion RFE/demand

12.9

126.3

122

T60

ICPC

Metabolic, Result test/procedure

8.6

124.8

160

189

SPAT1342

SPAT

Referral to specialised care

6.8

121.8

193

291

A99

ICPC

Disease/condition unspecnature/site

2.5

118.9

819

3490

R4110

NOMESCO Finland

Physiotherapy

1.9

117.8

2108

12994

R48

ICPC

Respiratory, Clarification/discussion RFE/demand

10.2

114.7

129

128

T90

ICD-10 Finland

Sequelae of injuries of head

21.5

114.0

ZXD10

NOMESCO Finland

Scheduled procedure

1.8

107.2

2738

18675

A97

ICPC

No disease

2.0

106.2

1412

7840

Z3231

NOMESCO Finland

Registered nurse

1.8

104.5

2060

12998

S48

ICPC

Skin, Clarification/discussion RFE/demand

11.4

103.5

108

T69

ICPC

Metabolic, Other reason for encounter NEC

10.1

102.6

116

QBE99, ,

SPAT

8.0

98.6

134

170

S54

ICPC

Skin, Repair/fix-suture/cast/prosth device

3.5

96.5

338

986

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

2.4

96.0

755

3402

WX290, ,

SPAT

3.4

95.9

363

1113

Z3226

NOMESCO Finland

Physiotherapist

1.9

91.1

1387

8016

SPAT1283

SPAT

Restricted health certificate

1.9

91.0

1292

7295

T31

ICPC

Metabolic, Medical examin/health eval partial

7.3

87.0

128

178

S29

ICPC

Skin symptom/complaint other

1.9

86.2

1413

8345

SPAT1325

SPAT

Vaccination

1.7

85.2

2325

15898

T62

ICPC

Metabolic, Administrative procedure

13.2

84.3

A61

ICPC

General and Unspecified, Result examination/test/record/letter from other provider

7.0

83.6

127

183

ZXE10

NOMESCO Finland

More than one and less than three hours

1.7

81.0

2472

17349

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.6

78.7

3124

23345

WZA30, ,

SPAT

7.6

77.4

110

147

L17

ICPC

Foot/toe symptom/complaint

1.7

76.7

2004

13470

S29

ICD-10 Finland

Other and unspecified injuries of thorax

21.7

75.4

ZXE00

NOMESCO Finland

One hour or less

1.6

74.4

2668

19381

T48

ICPC

Metabolic, Clarification/discussion RFE/demand

9.6

73.9

R05

ICPC

Cough

1.7

71.6

1700

11106

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.8

69.8

1167

6889

TNB11, ,

SPAT

9.7

69.8

L02

ICPC

Back symptom/complaint

2.1

69.8

745

3778

S56

ICPC

Skin, Dressing/pressure/compress/tamponade

6.9

68.8

107

158

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.8

67.5

1266

7726

F43

ICPC

Eye, Other diagnostic procedure

3.9

67.0

201

527

D48

ICPC

Digestive, Clarification/discussion RFE/demand

11.9

65.1

M79.6

ICD-10 Finland

Pain in limb

1.5

64.6

2805

21091

N43

ICPC

Neurological, Other diagnostic procedure

13.4

63.8

N02AX02

ATC

tramadol; systemic, rectal

1.5

63.5

2834

21414

K60

ICPC

Cardiovascular, Result test/procedure

6.8

63.4

147

XF400

NOMESCO Finland

ECG with 12 standard connections

1.8

63.4

1091

6481

D06

ICPC

Abdominal pain localized other

2.1

62.3

649

3254

S18

ICD-10 Finland

Traumatic amputation at neck level

16.2

62.3

U60

ICPC

Urological, Result test/procedure

8.0

61.2

105

N02BE01

ATC

paracetamol; systemic, rectal

1.8

59.8

6047

54488

S21

ICPC

Skin texture symptom/complaint

1.8

59.4

998

5876

UJF32, ,

SPAT

3.1

57.1

240

783

L12

ICPC

Hand/finger symptom/complaint

1.7

56.0

1124

6957

ZXA05

NOMESCO Finland

Left side

1.6

55.1

1589

10800

M54.5

ICD-10 Finland

Low back pain

1.5

54.7

2368

17625

A99

ICD-10 Finland

Unspecified viral haemorrhagic fever

+∞

54.2

A69

ICPC

General and Unspecified, Other reason for encounter NEC

3.0

54.2

239

802

S21

ICD-10 Finland

Open wound of thorax

18.0

53.3

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

53.1

3241

25808

WX002

NOMESCO Finland

Sedation and analgesia

1.7

52.7

1276

8291

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.5

52.6

2408

18095

D82

ICPC

Teeth/gum disease

1.5

52.0

2438

18396

R07

ICPC

Sneezing/nasal congestion

2.2

51.5

486

2341

T66

ICPC

Metabolic, Referral to non-MD provider

9.2

51.2

N01

ICPC

Headache

1.8

50.8

783

4477

TNG11, ,

SPAT

8.6

50.2

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.8

49.6

887

5301

SPAT1192

SPAT

Gynaecological examination

2.0

49.4

579

3023

L28

ICD-10 Finland

Lichen simplex chronicus and prurigo

5.5

49.2

178

H51

ICPC

Ear, I&d/flush/aspiration

4.2

49.0

132

320

R52.9

ICD-10 Finland

Pain, unspecified

1.9

48.2

669

3696

S50

ICPC

Skin, Medication/prescr/renewal

5.6

47.1

160

F48

ICPC

Eye, Clarification/discussion RFE/demand

14.6

46.7

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.1

46.5

442

2134

TNX00, ,

SPAT

4.5

46.5

115

261

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

4.0

46.3

133

338

JFA15, ,

SPAT

5.9

46.3

142

U48

ICPC

Urological, Clarification/discussion RFE/demand

9.9

46.2

B44

ICPC

Blood and Immunity, Preventive immunization/medic

8.4

46.2

WZB00, ,

SPAT

2.0

46.0

563

2982

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.8

45.9

717

4110

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.6

45.7

278

1106

M54.4

ICD-10 Finland

Lumbago with sciatica

1.6

45.6

1155

7563

R02

ICPC

Shortness of breath/dyspnoea

1.7

44.9

851

5161

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

2.8

44.9

236

872

A98

ICPC

Health maint/preventive medicine

2.6

43.8

6812

64900

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.1

43.1

443

2203

Z71.8

ICD-10 Finland

Other specified counselling

1.5

42.7

2008

15027

A50

ICPC

General and Unspecified, Medication/prescr/renewal

2.4

42.5

288

1205

TQW40, ,

SPAT

2.0

42.1

506

2661

E78

ICD-10 Finland

Disorders of lipoprotein metabolism and other lipidaemias

2.5

42.0

263

1060

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

3.0

42.0

189

642

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.1

41.8

445

2241

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

3.4

41.1

150

449

ZXD20

NOMESCO Finland

Day surgery

1.7

40.8

825

5085

ZY010

NOMESCO Finland

Hospital outpatient

2.1

40.7

379

1815

D19

ICPC

Teeth/gum symptom/complaint

1.5

40.4

1813

13419

ZXA00

NOMESCO Finland

Right side

1.5

40.0

1624

11775

XF600

NOMESCO Finland

Bloodpressure measurement

2.0

40.0

452

2325

D11

ICPC

Diarrhoea

1.7

39.9

777

4738

W90

ICD-10 Finland

Exposure to other nonionizing radiation

88.6

39.8

SCF01

NOMESCO Finland

Preventive oral care by dental hygienist or dental assistant, restricted

2.5

39.5

248

1001

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.5

39.3

243

974

R4120

NOMESCO Finland

Occupational therapy

2.0

38.7

452

2353

L12

ICD-10 Finland

Pemphigoid

13.4

38.2

T30

ICPC

Metabolic, Medical examin/health eval complete

7.0

37.6

J01DB01

ATC

cefalexin; oral

1.5

37.1

5527

50156

R07.4

ICD-10 Finland

Chest pain, unspecified

1.5

36.9

1747

13021

U01

ICPC

Dysuria/painful urination

1.9

36.8

503

2758

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.1

36.6

375

1861

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.5

36.4

1161

7983

B34.9

ICD-10 Finland

Viral infection, unspecified

2.5

35.6

225

912

U02

ICPC

Urinary frequency/urgency

1.6

35.5

862

5558

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.0

35.0

369

1850

A28

ICPC

Limited function/disability NOS

1.6

34.8

979

6540

B99

ICD-10 Finland

Other and unspecified infectious diseases

3.0

34.6

150

499

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

2.7

34.5

192

731

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.3

34.1

273

1229

Z2446

NOMESCO Finland

Social worker

1.9

34.0

459

2506

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

2.9

33.8

162

570

M25.5

ICD-10 Finland

Pain in joint

1.4

33.6

1978

15287

J01FA06

ATC

roxithromycin; oral

1.4

33.5

2409

19256

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.5

33.1

1138

7937

A02BC02

ATC

pantoprazole; systemic

1.4

32.9

4299

37669

R06.0

ICD-10 Finland

Dyspnoea

1.4

32.6

1614

12084

EBA05, ,

SPAT

3.0

32.6

146

495

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

2.5

32.4

204

825

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

32.2

2666

21756

R51.80

ICD-10 Finland

Headache

1.5

32.0

974

6612

R03AC02

ATC

salbutamol; inhalant

1.3

31.9

3470

29501

R53

ICD-10 Finland

Malaise and fatigue

1.4

31.9

1446

10649

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.1

31.8

297

1423

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.6

31.6

855

5652

M03BX02

ATC

tizanidine; oral

1.3

31.1

3916

33970

SPAT1213

SPAT

Examination of postural anomaly

3.3

30.9

117

359

J20

ICD-10 Finland

Acute bronchitis

1.7

30.8

627

3859

M54

ICD-10 Finland

Dorsalgia

1.6

30.8

772

5008

R42

ICD-10 Finland

Dizziness and giddiness

1.5

30.8

1335

9739

TPH04

NOMESCO Finland

Cathetrisation of vein

1.5

30.8

1343

9809

N17

ICPC

Vertigo/dizziness

1.6

30.5

734

4716

QDE99, ,

SPAT

7.0

30.4

D09

ICPC

Nausea

2.1

30.0

307

1522

R05

ICD-10 Finland

Cough

1.4

29.9

1325

9701

U07

ICPC

Urine symptom/complaint other

1.8

29.3

455

2594

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.4

29.0

209

900

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.0

29.0

339

1764

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.0

28.9

302

1510

M03BC01

ATC

orphenadrine (citrate); systemic

1.4

28.9

1370

10149

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

28.8

1527

11537

Z3229

NOMESCO Finland

Other healthcare associate professional

1.7

28.8

518

3082

OAB30, ,

SPAT

4.3

28.7

170

K02

ICD-10 Finland

Dental caries

1.8

28.4

444

2537

WX105, ,

SPAT

4.2

28.3

180

R60

ICPC

Respiratory, Result test/procedure

7.0

28.3

QCE99, ,

SPAT

7.9

28.1

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

3.1

28.0

118

387

D01

ICPC

Abdominal pain/cramps general

1.6

27.8

733

4808

J01MA02

ATC

ciprofloxacin; systemic

1.3

27.7

2327

18907

F29

ICPC

Eye symptom/complaint other

1.7

27.7

590

3673

TND11, ,

SPAT

11.2

27.5

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.6

27.4

752

4979

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.6

27.2

630

4003

XF400, ,

SPAT

3.6

26.7

247

L05

ICPC

Flank/axilla symptom/complaint

1.8

26.6

377

2088

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.4

26.5

1230

9061

H81

ICD-10 Finland

Disorders of vestibular function

8.2

26.4

Z2445

NOMESCO Finland

Psychologist

2.0

26.3

276

1382

UJD10, ,

SPAT

2.6

26.2

158

627

L15

ICPC

Knee symptom/complaint

1.4

26.1

1406

10626

IEY01

NOMESCO Finland

Psychoeducation, individual

4.3

26.1

153

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.9

26.1

368

2036

A98.8

ICD-10 Finland

Other specified viral haemorrhagic fevers

+∞

26.0

WZC00

NOMESCO Finland

Treatment plan or consultation

1.3

26.0

2265

18459

SDA04

NOMESCO Finland

Demanding periodontal treatment

1.4

25.4

1669

13025

H01

ICPC

Ear pain/earache

1.6

25.4

720

4798

M01AH05

ATC

etoricoxib; oral

1.3

25.2

3837

33710

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

25.1

4624

41679

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.6

24.9

589

3761

R21

ICPC

Throat symptom/complaint

1.4

24.9

1274

9536

TDA90, ,

SPAT

1.9

24.9

316

1691

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.8

24.6

418

2444

L50

ICPC

Musculoskeletal, Medication/prescr/renewal

5.7

24.5

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.6

24.4

691

4603

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.6

24.3

560

3551

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.4

24.3

1392

10613

UJD02

NOMESCO Finland

Gastroscopy

1.9

23.6

282

1479

SAA01, ,

SPAT

3.4

23.6

244

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.4

23.3

1408

10821

R4190, ,

SPAT

7.0

23.3

H29

ICPC

Ear symptom/complaint other

1.5

23.2

670

4478

A06AC01

ATC

ispaghula (psylla seeds); oral

1.4

23.1

1470

11387

L60

ICPC

Musculoskeletal, Result test/procedure

6.5

23.0

P01AB01

ATC

metronidazole; oral, rectal

1.3

22.7

2332

19364

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

22.6

4639

42077

A04

ICD-10 Finland

Other bacterial intestinal infections

9.3

22.6

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

22.6

2711

22967

M01AB05

ATC

diclofenac; systemic, rectal

1.3

22.5

4109

36699

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.4

22.5

1140

8506

R3110

NOMESCO Finland

Psychosocial training

3.2

22.4

277

WX902

NOMESCO Finland

External defibrillation of heart

5.7

22.4

G44.2

ICD-10 Finland

Tension-type headache

1.5

22.2

783

5460

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.5

22.2

708

4836

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.5

22.0

896

6421

J01CA04

ATC

amoxicillin; systemic

1.3

21.8

5361

49687

AA1AD

NOMESCO Finland

CT of head and brain

1.3

21.7

1546

12172

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

2.6

21.7

129

509

B81

ICD-10 Finland

Other intestinal helminthiases, not elsewhere classified

38.7

21.7

X48

ICPC

Female Genital, Clarification/discussion RFE/demand

7.1

21.6

TLC00, ,

SPAT

2.6

21.5

122

470

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.2

21.5

187

872

J01

ICD-10 Finland

Acute sinusitis

1.8

21.5

324

1830

L03

ICD-10 Finland

Cellulitis

3.2

21.3

260

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.7

21.3

441

2721

RK323, ,

NOMESCO Finland

5.7

21.1

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.9

21.1

283

1542

P76

ICPC

Depressive disorder

1.7

21.1

378

2245

XX1VW, ,

SPAT

3.6

21.0

189

M03BC51

ATC

orphenadrine, combinations; systemic

1.3

21.0

1574

12475

I25

ICD-10 Finland

Chronic ischaemic heart disease

1.9

21.0

264

1408

P06

ICPC

Sleep disturbance

1.5

20.9

679

4650

S20

ICPC

Corn/callosity

2.5

20.9

135

554

L04

ICPC

Chest symptom/complaint

1.7

20.7

370

2196

L08

ICPC

Shoulder symptom/complaint

1.4

20.6

1261

9688

N03AX12

ATC

[U] gabapentin; oral

1.4

20.4

939

6877

SPAT1016

SPAT

Examination of vision

1.8

20.3

301

1691

A02BC01

ATC

omeprazole; systemic

1.3

20.3

1559

12391

B01AB05

ATC

enoxaparin; parenteral

1.3

20.3

1808

14674

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

20.3

2111

17493

J45

ICD-10 Finland

Asthma

1.5

20.3

589

3939

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.9

20.3

278

1525

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.4

20.0

831

5975

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

19.8

1287

9974

WVA20

NOMESCO Finland

Medicine administration

2.2

19.8

163

744

A04

ICPC

Weakness/tiredness general

1.4

19.7

838

6052

R29

ICPC

Respiratory symptom/complaint other

1.7

19.6

394

2412

WX402

NOMESCO Finland

General anaesthesia

1.4

19.6

1264

9784

QAA25, ,

SPAT

4.9

19.6

H48

ICPC

Ear, Clarification/discussion RFE/demand

6.8

19.5

OAB31, ,

SPAT

6.0

19.4

SDA04, ,

SPAT

5.4

19.4

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.4

19.3

128

532

N06AX21

ATC

duloxetine; oral

1.5

19.1

658

4561

K02.1

ICD-10 Finland

Caries of dentine

1.3

18.9

3686

32849

C07AB07

ATC

bisoprolol; oral

1.3

18.9

2768

23869

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

2.4

18.7

133

571

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.3

18.7

1743

14210

M54.8

ICD-10 Finland

Other dorsalgia

1.8

18.5

261

1445

R60.0

ICD-10 Finland

Localized oedema

1.5

18.5

675

4731

J01AA02

ATC

doxycycline; systemic

1.3

18.5

4823

44406

A02BC03

ATC

lansoprazole; oral

1.3

18.4

1590

12823

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.3

18.3

1574

12682

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.3

18.3

1376

10883

WVA20, ,

SPAT

2.1

18.2

163

770

N06AX11

ATC

mirtazapine; oral

1.3

18.1

1949

16176

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.3

18.0

1795

14745

Z02.4

ICD-10 Finland

Examination for driving licence

1.3

17.9

1549

12487

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

2.3

17.9

135

595

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

3.0

17.8

263

IER03

NOMESCO Finland

Psychiatric disorder-specific group intervention

6.0

17.7

B50

ICPC

Blood and Immunity, Medication/prescr/renewal

5.6

17.7

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.3

17.6

1294

10196

C10AA01

ATC

simvastatin; oral

1.3

17.5

2299

19524

R09

ICPC

Sinus symptom/complaint

1.6

17.5

458

2992

J01FA09

ATC

clarithromycin; systemic

1.3

17.5

1799

14832

P03

ICPC

Feeling depressed

1.5

17.4

547

3719

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

17.4

1102

8492

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.4

17.4

698

4981

K02.0

ICD-10 Finland

Caries limited to enamel

1.4

17.4

1064

8157

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.3

17.4

1160

9011

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.4

17.3

989

7499

M01AE01

ATC

ibuprofen; systemic, rectal

1.3

17.3

5923

56164

L03

ICPC

Low back symptom/complaint

1.3

17.3

1595

12961

A08

ICPC

Swelling

1.8

17.3

282

1632

S97

ICD-10 Finland

Crushing injury of ankle and foot

42.0

17.3

D10

ICPC

Vomiting

1.7

17.2

346

2121

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

2.5

17.1

103

410

K39

ICPC

Cardiovascular, Physical function test

5.8

17.1

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

17.1

983

7463

M79.1

ICD-10 Finland

Myalgia

1.4

17.0

812

5976

S22

ICPC

Nail symptom/complaint

1.6

17.0

362

2251

P76

ICD-10 Finland

Other intestinal obstruction of newborn

50.1

17.0

J11

ICD-10 Finland

Influenza, virus not identified

2.7

16.9

320

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.3

16.9

2536

21845

SDA05

NOMESCO Finland

Very demanding periodontal treatment

1.6

16.9

384

2426

LC2DE

NOMESCO Finland

Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods

1.9

16.8

221

1198

TNG10, ,

SPAT

5.3

16.8

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.5

16.7

495

3323

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.5

16.6

503

3391

SCA01

NOMESCO Finland

Preventive oral health care, short

1.3

16.6

1763

14570

K03.8

ICD-10 Finland

Other specified diseases of hard tissues of teeth

15.0

16.6

A11

ICPC

Chest pain NOS

1.5

16.6

458

3028

K78

ICPC

Atrial fibrillation/flutter

1.6

16.6

401

2572

A01

ICPC

Pain general/multiple sites

1.5

16.5

505

3413

L13

ICPC

Hip symptom/complaint

1.4

16.5

977

7448

A46

ICD-10 Finland

Erysipelas

1.4

16.4

801

5914

R43

ICPC

Respiratory, Other diagnostic procedure

3.5

16.4

157

N03AX16

ATC

[U] pregabalin

1.3

16.4

1301

10349

I10

ICD-10 Finland

Essential (primary) hypertension

1.2

16.3

3470

31010

J01DA01

ATC

[U] cefalexin

1.2

16.3

3699

33282

R06AX27

ATC

desloratadine; oral

1.3

16.3

1663

13677

ZXE20

NOMESCO Finland

More than three and less than five hours

1.4

16.2

757

5548

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.3

16.2

1210

9544

XA800

NOMESCO Finland

Neuropsychological investigation

1.8

16.2

257

1476

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.4

16.1

802

5941

SAA02

NOMESCO Finland

Basic examination of mouth

1.2

16.1

4217

38497

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

2.7

16.0

318

W85

ICD-10 Finland

Exposure to electric transmission lines

24.5

16.0

P01

ICD-10 Finland

Fetus and newborn affected by maternal complications of pregnancy

24.5

16.0

K30

ICD-10 Finland

Functional dyspepsia

1.5

15.9

613

4338

K59.09

ICD-10 Finland

Constipation, unspecified

1.6

15.8

371

2361

K03.00

ICD-10 Finland

Approximal wear

1.6

15.8

393

2536

H66

ICD-10 Finland

Suppurative and unspecified otitis media

2.0

15.7

166

835

A05

ICPC

Feeling ill

1.6

15.7

348

2185

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.4

15.7

923

7023

J01FA10

ATC

azithromycin; systemic

1.2

15.6

3488

31266

Z37.0

ICD-10 Finland

Single live birth

1.6

15.6

382

2457

K31

ICPC

Cardiovascular, Medical examin/health eval partial

3.8

15.6

125

F51.0

ICD-10 Finland

Nonorganic insomnia

1.4

15.6

878

6636

R07.3

ICD-10 Finland

Other chest pain

1.5

15.6

557

3886

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.4

15.4

741

5455

M02AA07

ATC

piroxicam; topical

1.3

15.4

1976

16680

H81

ICPC

Excessive ear wax

1.4

15.4

937

7168

SFA20

NOMESCO Finland

Two-surface restoration

1.2

15.3

3588

32297

R06AE07

ATC

cetirizine; oral

1.2

15.1

2584

22502

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.5

15.0

555

3898

K62

ICPC

Cardiovascular, Administrative procedure

13.9

15.0

RK250, ,

NOMESCO Finland

3.8

15.0

115

B48

ICPC

Blood and Immunity, Clarification/discussion RFE/demand

10.8

14.9

R2110

NOMESCO Finland

Giving the first information

1.6

14.9

363

2334

PD5BD

NOMESCO Finland

Extensive CT of aorta

2.3

14.8

113

502

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.4

14.7

736

5457

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

2.3

14.6

113

504

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.5

14.6

509

3534

SFA30

NOMESCO Finland

Three-surface restoration

1.2

14.6

2462

21389

E0000UV, ,

ATC

1.2

14.6

2447

21246

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.1

14.4

142

698

K05.3

ICD-10 Finland

Chronic periodontitis

1.7

14.3

279

1696

WYA30, ,

SPAT

3.2

14.3

177

D11

ICD-10 Finland

Benign neoplasm of major salivary glands

17.0

14.3

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.8

14.3

215

1217

IBA03

NOMESCO Finland

Psychotherapy evaluation

3.0

14.2

209

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.6

14.2

312

1956

L15, ,

ICD-10 Finland

13.4

14.2

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

0.6

14.2

307

4768

N17

ICD-10 Finland

Acute renal failure

5.3

14.1

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.3

14.0

1230

9895

D12

ICPC

Constipation

1.8

14.0

193

1063

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.5

13.9

510

3576

W92

ICD-10 Finland

Exposure to excessive heat of man-made origin

5.2

13.9

ZXA10

NOMESCO Finland

Bilateral

1.3

13.8

1000

7836

C08CA01

ATC

amlodipine; oral

1.2

13.8

2100

18020

A97

ICD-10 Finland

Dengue

20.0

13.7

F32

ICD-10 Finland

Depressive episode

1.6

13.7

283

1747

L13

ICD-10 Finland

Other bullous disorders

10.4

13.7

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.5

13.6

498

3490

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

1.8

13.5

207

1177

X21

ICPC

Breast sympt/compl female other

2.2

13.4

112

517

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.5

13.3

435

2979

T61

ICPC

Metabolic, Result examination/test/record/letter from other provider

18.2

13.3

TND32

NOMESCO Finland

Custom moulded splint, wrist or hand

2.5

13.3

343

R74

ICPC

Upper respiratory infection acute

1.2

13.3

1816

15390

R02

ICD-10 Finland

Gangrene, not elsewhere classified

4.8

13.3

H04

ICPC

Ear discharge

1.8

13.2

185

1025

N30

ICD-10 Finland

Cystitis

1.5

13.2

410

2781

R12

ICD-10 Finland

Heartburn

1.5

13.1

429

2939

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

3.0

13.1

192

B43

ICPC

Blood and Immunity, Other diagnostic procedure

5.9

13.0

M54.3

ICD-10 Finland

Sciatica

1.6

12.9

325

2104

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.4

12.9

517

3684

WX306

NOMESCO Finland

Lumbar epidural anesthesy

1.6

12.8

336

2196

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.3

12.8

1284

10492

K80

ICPC

Cardiac arrhythmia NOS

1.5

12.8

425

2922

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

2.4

12.8

368

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.4

12.8

624

4604

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.4

12.7

693

5203

J01FF01

ATC

clindamycin; systemic

1.3

12.6

1503

12536

U02, ,

ICD-10 Finland

69.9

12.6

S22

ICD-10 Finland

Fracture of rib(s), sternum and thoracic spine

4.8

12.6

R01AD09

ATC

mometasone; nasal

1.2

12.5

2643

23374

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.5

12.5

382

2582

U07

ICD-10 Finland

Emergency use of U07

17.3

12.5

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.4

12.5

530

3817

H02AB06

ATC

prednisolone; systemic

1.2

12.4

2746

24386

J06

ICD-10 Finland

Acute upper respiratory infections of multiple and unspecified sites

1.7

12.4

214

1261

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

1.6

12.3

308

1992

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.3

12.3

816

6311

F73

ICPC

Eye infection/inflammation other

2.1

12.3

118

575

M54.2

ICD-10 Finland

Cervicalgia

1.5

12.3

426

2954

Z34

ICD-10 Finland

Supervision of normal pregnancy

1.8

12.2

184

1042

K59.1

ICD-10 Finland

Functional diarrhoea

1.6

12.2

288

1837

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

2.2

12.2

103

478

UJH02

NOMESCO Finland

Anoscopy

1.7

12.2

216

1282

N07BA03

ATC

varenicline; oral

1.6

12.2

258

1604

W31

ICPC

Pregnancy, Medical examin/health eval partial

2.7

12.2

228

H25.8

ICD-10 Finland

Other senile cataract

0.6

12.2

239

3798

IER01

NOMESCO Finland

Psychoeducation, group

3.2

12.1

148

NHG76

NOMESCO Finland

Arthroplasty of other tarsometatarsal joint

2.4

12.1

322

K85

ICPC

Elevated blood pressure

1.3

12.1

821

6371

A39

ICPC

General and Unspecified, Physical function test

5.5

12.1

W48

ICPC

Pregnancy, Clarification/discussion RFE/demand

4.6

12.1

EBA10, ,

SPAT

3.1

12.1

164

WX320

NOMESCO Finland

Spinalanesthesy

1.3

12.0

1309

10794

X57

ICD-10 Finland

Unspecified privation

2.0

12.0

128

648

R50

ICD-10 Finland

Fever of other and unknown origin

4.1

12.0

P20

ICD-10 Finland

Intrauterine hypoxia

21.3

12.0

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

2.9

12.0

186

X14

ICPC

Vaginal discharge

2.1

11.8

110

530

IBZ02

NOMESCO Finland

Somatic assessment of psychiatric patient

3.5

11.8

111

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.4

11.8

519

3761

R03BA02

ATC

budesonide; inhalant

1.3

11.8

950

7546

H25.1

ICD-10 Finland

Senile nuclear cataract

1.3

11.8

1276

10517

TNH33

NOMESCO Finland

Custom moulded brace, ankle or foot

2.2

11.7

408

K08.80

ICD-10 Finland

Toothache NOS

1.4

11.7

459

3257

D60

ICPC

Digestive, Result test/procedure

8.9

11.7

N05AH04

ATC

quetiapine; oral

1.3

11.7

954

7589

Z01.2

ICD-10 Finland

Dental examination

1.2

11.7

2701

24047

VALMI, ,

NOMESCO Finland

0.8

11.7

937

11647

R11

ICD-10 Finland

Nausea and vomiting

1.4

11.7

458

3252

N01

ICD-10 Finland

Rapidly progressive nephritic syndrome

30.0

11.6

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

1.8

11.6

177

1007

W92

ICPC

Compl labour/ delivery livebirth

2.2

11.5

430

M01AE02

ATC

naproxen; oral, rectal

1.2

11.4

3382

30763

U72

ICPC

Urethritis

2.0

11.4

125

640

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.2

11.4

2328

20483

H92.0

ICD-10 Finland

Otalgia

1.5

11.3

328

2192

SFA10

NOMESCO Finland

One-surface restoration

1.2

11.3

3309

30050

D07AC01

ATC

betamethasone; topical

1.2

11.3

2030

17633

X15

ICPC

Vaginal symptom/complaint other

1.7

11.3

187

1089

R60.9

ICD-10 Finland

Oedema, unspecified

1.6

11.3

276

1776

R03DC03

ATC

montelukast; oral

1.3

11.3

885

7000

P74

ICD-10 Finland

Other transitory neonatal electrolyte and metabolic disturbances

35.0

11.2

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

11.2

2780

24880

R4190

NOMESCO Finland

Nutritional therapy

1.6

11.2

228

1405

R74

ICD-10 Finland

Abnormal serum enzyme levels

4.0

11.2

G04CA02

ATC

tamsulosin; oral

1.3

11.1

1200

9875

M53

ICD-10 Finland

Other dorsopathies, not elsewhere classified

2.9

11.1

172

J45.9

ICD-10 Finland

Asthma, unspecified

1.3

11.1

1005

8098

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

1.9

11.1

138

738

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.3

11.0

729

5633

ECB00, ,

SPAT

11.1

11.0

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.6

11.0

253

1606

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

2.4

10.9

313

M77.1

ICD-10 Finland

Lateral epicondylitis

1.4

10.9

403

2828

S80.0

ICD-10 Finland

Contusion of knee

1.5

10.9

384

2672

R03BA01

ATC

beclometasone; inhalant

1.3

10.9

719

5555

A02BC05

ATC

esomeprazole; systemic

1.2

10.9

2289

20168

C10AA07

ATC

rosuvastatin; oral

1.2

10.9

1731

14854

D07AB02

ATC

hydrocortisone butyrate; topical

1.2

10.9

1606

13678

TPH07

NOMESCO Finland

Cathetrisation of artery

1.4

10.8

589

4420

A85

ICPC

Adverse effect medical agent

2.6

10.8

231

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.0

10.8

120

618

W60

ICPC

Pregnancy, Result test/procedure

4.2

10.8

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.4

10.8

553

4113

R31

ICD-10 Finland

Unspecified haematuria

1.4

10.7

504

3693

J01DA06

ATC

[U] cefuroxime

1.3

10.7

741

5763

U29

ICPC

Urinary symptom/complaint other

1.8

10.7

153

855

S15

ICPC

Foreign body in skin

1.5

10.7

332

2253

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.2

10.7

3311

30164

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.2

10.7

3137

28449

ZYC01

NOMESCO Finland

Remote contact by phone

1.5

10.7

318

2140

IGY99

NOMESCO Finland

Other psychiatric treatment contact

1.9

10.6

122

635

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.4

10.6

461

3333

NG1EA

NOMESCO Finland

Knee X-ray examination with wrench

2.3

10.6

349

N03AX09

ATC

lamotrigine; oral

1.6

10.6

250

1598

M48.0

ICD-10 Finland

Spinal stenosis

1.4

10.5

607

4595

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

1.7

10.5

200

1211

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

1.9

10.5

132

708

B01AF02

ATC

apixaban; oral

1.3

10.5

623

4738

G47.3

ICD-10 Finland

Sleep apnoea

1.2

10.5

1245

10354

WZA00

NOMESCO Finland

Concise certificate

1.5

10.5

344

2361

ZXD05

NOMESCO Finland

Urgent procedure

1.2

10.5

1686

14473

H02

ICD-10 Finland

Other disorders of eyelid

9.1

10.5

TAD08

NOMESCO Finland

Sympathetic block on sacral Level

9.1

10.5

L82

ICD-10 Finland

Seborrhoeic keratosis

1.3

10.5

925

7429

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.6

10.5

234

1476

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

0.5

10.5

120

2197

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.5

10.4

337

2307

TFP20

NOMESCO Finland

Cardiodefibrillation

1.5

10.4

360

2498

EBA30, ,

SPAT

3.3

10.4

111

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.2

10.4

1568

13376

SPAT1256

SPAT

Intramuscular and subcutaneous injection

0.8

10.3

1830

20928

S22.3

ICD-10 Finland

Fracture of rib

1.5

10.3

369

2575

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.5

10.3

360

2502

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.5

10.3

331

2263

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.3

10.3

703

5457

C10AA05

ATC

atorvastatin; oral

1.2

10.3

2271

20075

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.5

10.2

284

1882

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.4

10.2

465

3388

H13

ICD-10 Finland

Disorders of conjunctiva in diseases classified elsewhere

23.4

10.2

S61.0

ICD-10 Finland

Open wound of finger(s) without damage to nail

1.4

10.2

493

3629

H04.10

ICD-10 Finland

Dry eye syndrome

1.4

10.2

568

4277

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

1.7

10.2

170

994

H02AB07

ATC

prednisone; oral

1.3

10.2

684

5298

E10

ICD-10 Finland

Type 1 diabetes mellitus

2.0

10.1

102

508

R23.3

ICD-10 Finland

Spontaneous ecchymoses

2.0

10.1

107

543

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

1.7

10.0

193

1173

KH1CD

NOMESCO Finland

Very extensive urinary tract ultrasound examination

2.5

10.0

246

F99

ICPC

Eye/adnexa disease other

3.1

10.0

134

WX408

NOMESCO Finland

General anesthesy, balanced

1.2

10.0

1462

12423

T43

ICPC

Metabolic, Other diagnostic procedure

10.0

W90

ICPC

Uncompl labour/delivery livebirth

1.6

9.9

198

1214

WZC00, ,

SPAT

1.4

9.9

542

4069

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

1.5

9.9

280

1863

K96

ICPC

Haemorrhoids

1.8

9.9

143

803

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.2

9.9

1318

11095

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.4

9.9

429

3104

-31

ICPC

Medical examin/health eval partial

0.6

9.8

139

2398

N06AB03

ATC

fluoxetine; oral

1.3

9.8

628

4830

A01

ICD-10 Finland

Typhoid and paratyphoid fevers

26.0

9.8

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.2

9.8

1463

12455

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

1.5

9.8

280

1869

RS222, ,

NOMESCO Finland

2.3

9.8

298

R03AC03

ATC

terbutaline; inhalant

1.3

9.8

712

5575

P01

ICPC

Feeling anxious/nervous/tense

1.3

9.7

618

4746

C10AX09

ATC

ezetimibe; oral

1.3

9.7

815

6499

J31.0

ICD-10 Finland

Chronic rhinitis

1.4

9.7

436

3171

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.5

9.7

278

1856

J02AC01

ATC

fluconazole; systemic

1.2

9.7

2099

18497

IEY08

NOMESCO Finland

Psychiatric coaching, domestic and community skills

4.1

9.7

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.3

9.7

621

4778

N06AB06

ATC

sertraline; oral

1.3

9.6

587

4481

U01, ,

ICD-10 Finland

55.0

9.6

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.4

9.6

493

3666

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.4

9.6

392

2805

M70.6

ICD-10 Finland

Trochanteric bursitis

1.3

9.6

639

4942

L72.1

ICD-10 Finland

Trichilemmal cyst

1.5

9.6

339

2363

WX203

NOMESCO Finland

Infraclavicular plexus blockade

1.9

9.6

122

659

S02

ICPC

Pruritus

1.7

9.6

182

1104

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.2

9.5

1090

9018

IBA02

NOMESCO Finland

Evaluation of need for psychiatric rehabilitation

2.8

9.5

165

207

Kela drug reimbursment

Chronic arrhythmias

1.3

9.5

753

5963

T78.4

ICD-10 Finland

Allergy, unspecified

1.6

9.4

233

1506

ZXC20

NOMESCO Finland

Use of chemical agents

2.0

9.4

460

R52.2

ICD-10 Finland

Other chronic pain

1.6

9.4

186

1139

U71, ,

ICD-10 Finland

100.1

9.4

A98.0

ICD-10 Finland

Crimean-Congo haemorrhagic fever

+∞

9.4

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.2

9.4

1147

9561

L14

ICPC

Leg/thigh symptom/complaint

1.4

9.3

399

2878

W19

ICD-10 Finland

Unspecified fall

1.4

9.3

503

3773

L11

ICPC

Wrist symptom/complaint

1.4

9.3

450

3317

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.4

9.3

335

2345

U05

ICPC

Urination problems other

1.5

9.3

249

1641

N39

ICD-10 Finland

Other disorders of urinary system

2.7

9.2

185

M01AH01

ATC

celecoxib; oral

1.3

9.2

898

7295

K01

ICPC

Heart pain

2.3

9.2

294

M20.2

ICD-10 Finland

Hallux rigidus

1.7

9.1

154

904

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

1.9

9.1

116

626

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

9.1

2167

19229

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

1.5

9.1

244

1606

SDE04

NOMESCO Finland

Periodontal treatment by dental hygienist, very extensive

1.4

9.1

499

3749

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.2

9.1

1340

11382

R07.0

ICD-10 Finland

Pain in throat

1.4

9.1

360

2564

J05AB11

ATC

valaciclovir; oral

1.3

9.0

729

5785

OAA11, ,

SPAT

1.6

9.0

201

1270

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

9.0

4168

38982

IFA99

NOMESCO Finland

Other psychiatric pharmacotherapy service

2.7

9.0

165

T99

ICPC

Endocr/metab/nutrit disease other

2.1

9.0

421

SGA01

NOMESCO Finland

Emergency treatment

1.3

8.9

868

7046

TNH11, ,

SPAT

18.6

8.9

M54.6

ICD-10 Finland

Pain in thoracic spine

1.4

8.9

367

2631

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.4

8.9

400

2912

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

1.9

8.9

512

ZXY60

NOMESCO Finland

2-person team, nurses

3.2

8.9

102

JDA05, ,

SPAT

12.5

8.8

P58

ICPC

Psychological, Therapeutic counselling/listening

2.0

8.8

492

A08

ICD-10 Finland

Viral and other specified intestinal infections

4.5

8.8

R55

ICD-10 Finland

Syncope and collapse

1.3

8.8

537

4102

IAB07

NOMESCO Finland

Consultation concerning a patient with self-harm intention

3.8

8.8

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.2

8.8

1642

14265

M01AC06

ATC

meloxicam; systemic, rectal

1.2

8.7

1964

17332

SPAT1216

SPAT

Assessment of functional ability

1.3

8.7

753

6024

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

0.7

8.7

252

3685

XKD00

NOMESCO Finland

Uroflowmetry

1.3

8.7

791

6368

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

0.8

8.6

968

11618

B01AA03

ATC

warfarin; systemic

1.3

8.6

895

7320

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.5

8.6

253

1699

R05FB02

ATC

cough suppressants and expectorants; systemic

1.2

8.6

1958

17292

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.2

8.6

1018

8448

JN4BD

NOMESCO Finland

Extensive body CT

1.3

8.6

518

3949

EBA00

NOMESCO Finland

Extraction of tooth

1.2

8.6

2047

18154

N06AX16

ATC

venlafaxine; oral

1.3

8.5

724

5781

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.3

8.5

584

4535

CS494

NOMESCO Finland

Other visual field testing

0.3

8.5

754

WYA02, ,

SPAT

20.0

8.5

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.6

8.4

184

1158

G83.4

ICD-10 Finland

Cauda equina syndrome

3.6

8.4

M13.9

ICD-10 Finland

Arthritis, unspecified

1.4

8.4

368

2669

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

2.2

8.4

287

A03

ICD-10 Finland

Shigellosis

12.7

8.4

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.4

8.3

327

2324

R03AK07

ATC

formoterol and budesonide; inhalant

1.2

8.3

1095

9193

SPAT1262

SPAT

Handing over of treatment supplies

0.8

8.3

597

7547

JL5AG

NOMESCO Finland

Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet

2.5

8.3

208

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.4

8.3

332

2371

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.5

8.2

284

1972

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.5

8.2

225

1490

F01

ICPC

Eye pain

1.7

8.2

144

856

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

1.5

8.2

271

1865

H02

ICPC

Hearing complaint

1.3

8.2

676

5378

A68

ICPC

General and Unspecified, Other referral NEC

3.3

8.2

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

1.8

8.2

121

686

D25

ICPC

Abdominal distension

1.9

8.1

514

H91.8

ICD-10 Finland

Other specified hearing loss

2.4

8.1

228

N17.8

ICD-10 Finland

Other acute renal failure

2.2

8.1

304

-44

ICPC

Preventive immunization/medic

0.7

8.1

200

3015

H10

ICD-10 Finland

Conjunctivitis

1.4

8.1

369

2695

R96

ICD-10 Finland

Other sudden death, cause unknown

17.2

8.1

S01

ICPC

Pain/tenderness of skin

1.5

8.1

229

1529

R50

ICPC

Respiratory, Medication/prescr/renewal

4.0

8.0

N17.0

ICD-10 Finland

Acute renal failure with tubular necrosis

3.3

8.0

H26.9

ICD-10 Finland

Cataract, unspecified

2.0

8.0

405

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.4

8.0

433

3248

T07

ICPC

Weight gain

2.1

8.0

365

H53.9

ICD-10 Finland

Visual disturbance, unspecified

1.6

8.0

173

1086

N02BF01

ATC

gabapentin; oral

1.4

8.0

413

3077

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.4

8.0

406

3017

L60.0

ICD-10 Finland

Ingrowing nail

1.5

8.0

233

1565

Z3232

NOMESCO Finland

Midwife

1.4

8.0

317

2260

N06AB10

ATC

escitalopram; oral

1.2

8.0

1064

8940

C03CA01

ATC

furosemide; systemic

1.2

8.0

1412

12192

F34.1

ICD-10 Finland

Dysthymia

1.6

8.0

175

1103

TKC20

NOMESCO Finland

Catheterisation of bladder

1.4

7.9

318

2270

P74

ICPC

Anxiety disorder/anxiety state

1.5

7.9

209

1374

TNX10, ,

SPAT

2.6

7.9

171

RJ128, ,

NOMESCO Finland

4.4

7.9

A21.9

ICD-10 Finland

Tularaemia, unspecified

4.4

7.9

J46

ICD-10 Finland

Status asthmaticus

1.7

7.9

134

791

ZXY58

NOMESCO Finland

2-person team, nurse-occupational therapist

6.6

7.9

K03.66

ICD-10 Finland

Tooth plaque

1.4

7.8

399

2965

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.4

7.8

416

3112

F02

ICPC

Red eye

1.5

7.8

219

1458

IEY02

NOMESCO Finland

Intensified psychiatric outpatient care, Assertive Community Treatment (ACT)

3.6

7.8

K05

ICPC

Irregular heartbeat other

1.6

7.8

153

937

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

2.2

7.8

270

K03.64

ICD-10 Finland

Dental calculus supragingival

1.2

7.8

1756

15474

E04.9

ICD-10 Finland

Nontoxic goitre, unspecified

1.8

7.8

102

557

R52.0

ICD-10 Finland

Acute pain

1.6

7.8

167

1046

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

1.9

7.8

458

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

1.9

7.8

472

OAB32, ,

SPAT

3.5

7.8

MA5AE

NOMESCO Finland

Morphology ultrasound screening, weeks 18+0 to 21+6 of gestation

1.5

7.8

210

1387

K85

ICD-10 Finland

Acute pancreatitis

2.0

7.8

369

L95

ICPC

Osteoporosis

1.6

7.8

162

1008

R32

ICD-10 Finland

Unspecified urinary incontinence

1.7

7.8

132

779

T90

ICPC

Diabetes non-insulin dependent

1.2

7.7

1229

10500

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.3

7.7

496

3816

K22

ICPC

Risk factor cardiovascular disease

1.4

7.7

280

1963

TNX99

NOMESCO Finland

Other orthopaedic minor procedure

1.7

7.7

137

818

R10.0

ICD-10 Finland

Acute abdomen

1.6

7.7

161

1003

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.2

7.7

1277

10957

ICC01

NOMESCO Finland

Psychiatric treatment plan, transfer to psychiatric outpatient clinic

3.1

7.7

101

RS210, ,

NOMESCO Finland

3.5

7.7

M75.5

ICD-10 Finland

Bursitis of shoulder

1.8

7.6

116

663

FN1CD

NOMESCO Finland

Very extensive CT of coronary arteries

2.6

7.6

168

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.5

7.6

202

1329

I20

ICD-10 Finland

Angina pectoris

2.0

7.6

372

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.3

7.6

642

5122

R01AD58

ATC

fluticasone, combinations; nasal

1.2

7.6

1301

11191

IBB01

NOMESCO Finland

Psychiatric functioning capacity evaluation

3.7

7.6

N28.9

ICD-10 Finland

Disorder of kidney and ureter, unspecified

3.7

7.6

A11, ,

ICD-10 Finland

18.3

7.6

H29, ,

ICD-10 Finland

18.3

7.6

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

1.7

7.6

124

724

Y77

ICD-10 Finland

Ophthalmic devices associated with adverse incidents

25.0

7.6

L62

ICPC

Musculoskeletal, Administrative procedure

11.8

7.6

K10.3

ICD-10 Finland

Alveolitis of jaws

1.5

7.6

237

1616

B81

ICPC

Anaemia vit B12/folate deficiency

1.6

7.6

179

1149

N30.0

ICD-10 Finland

Acute cystitis

1.2

7.5

798

6539

TLC02, ,

SPAT

2.3

7.5

236

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

1.8

7.5

113

644

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.3

7.5

649

5193

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.3

7.5

531

4144

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.4

7.5

404

3032

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.3

7.4

455

3477

S18

ICPC

Laceration/cut

1.2

7.4

2577

23464

T91

ICPC

Vitamin/nutritional deficiency

2.4

7.4

195

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.2

7.4

1432

12455

R01

ICPC

Pain respiratory system

1.9

7.4

439

C09CA06

ATC

candesartan; oral

1.2

7.4

1214

10407

RS220, ,

NOMESCO Finland

2.0

7.3

357

F39

ICD-10 Finland

Unspecified mood [affective] disorder

1.9

7.3

468

M62.6

ICD-10 Finland

Muscle strain

1.6

7.3

158

992

L04AX03

ATC

methotrexate; systemic

1.3

7.3

479

3696

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.4

7.3

385

2877

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.3

7.3

440

3355

A28

ICD-10 Finland

Other zoonotic bacterial diseases, not elsewhere classified

10.8

7.3

NK4AT

NOMESCO Finland

Puncture of joint with ultrasound guidance not elsewher classified

2.3

7.3

221

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.3

7.3

617

4928

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

1.7

7.3

119

696

XF612

NOMESCO Finland

Measurement of central venous pressure

4.1

7.3

EB1CA, ,

SPAT

2.4

7.2

209

A07AA02

ATC

nystatin; oral

1.4

7.2

270

1904

N06AX03

ATC

mianserin; oral

1.5

7.2

217

1467

R23

ICPC

Voice symptom/complaint

1.8

7.2

111

638

QDH05, ,

SPAT

4.3

7.2

D07AA02

ATC

hydrocortisone; topical

1.3

7.2

724

5900

SPAT1312

SPAT

General health counselling

0.8

7.2

1378

15747

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.5

7.2

193

1276

JN3AD

NOMESCO Finland

Abdominal CT examination

1.3

7.2

569

4507

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

2.1

7.1

287

H03

ICD-10 Finland

Disorders of eyelid in diseases classified elsewhere

30.0

7.1

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.3

7.1

561

4438

TNF11, ,

SPAT

20.0

7.1

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.3

7.1

450

3456

N06AX05

ATC

trazodone; oral

1.7

7.1

121

715

J01MA14

ATC

moxifloxacin; systemic

1.3

7.1

431

3292

OAA51, ,

SPAT

3.2

7.1

QBA10, ,

SPAT

7.9

7.1

G54.0

ICD-10 Finland

Brachial plexus disorders

1.7

7.1

122

724

IDR03

NOMESCO Finland

Systematic group therapy, dialectical behaviour therapy (DBT)

5.6

7.0

TKC10, ,

SPAT

8.8

7.0

C01DA14

ATC

isosorbide mononitrate; oral

1.3

7.0

666

5389

ZX090

NOMESCO Finland

Other technic of radiotherapy

1.7

7.0

128

771

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.3

7.0

682

5535

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.2

7.0

923

7740

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.4

7.0

259

1824

D07AB08

ATC

desonide; topical

1.3

7.0

541

4269

X60

ICPC

Female Genital, Result test/procedure

4.2

7.0

ACC51

NOMESCO Finland

Release of median nerve

1.4

7.0

354

2631

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

1.9

7.0

462

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.3

7.0

498

3891

S20.2

ICD-10 Finland

Contusion of thorax

1.4

7.0

251

1760

L20.8

ICD-10 Finland

Other atopic dermatitis

2.1

7.0

297

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

1.3

6.9

435

3337

S89.9

ICD-10 Finland

Unspecified injury of lower leg

1.6

6.9

167

1077

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

1.4

6.9

271

1928

ZYB04

NOMESCO Finland

Outreach service in patient’s home or everyday environment

2.9

6.9

102

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

1.6

6.9

172

1118

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.3

6.9

541

4279

D06

ICD-10 Finland

Carcinoma in situ of cervix uteri

7.5

6.9

M01AX17

ATC

nimesulide; oral

1.2

6.9

1191

10251

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

1.4

6.8

308

2246

L88

ICD-10 Finland

Pyoderma gangrenosum

4.1

6.8

OAA21, ,

SPAT

6.7

6.8

M81.9

ICD-10 Finland

Osteoporosis, unspecified

1.5

6.8

184

1220

L95

ICD-10 Finland

Vasculitis limited to skin, not elsewhere classified

40.0

6.8

MA3AE

NOMESCO Finland

Combined first trimester screening

1.5

6.7

200

1350

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.4

6.7

322

2371

AN1

Coronary angiography

1.3

6.7

508

3997

E66.8

ICD-10 Finland

Other obesity

1.4

6.7

261

1855

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.4

6.7

346

2578

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.4

6.7

286

2066

-, ,

ICD-10 Finland

1.8

6.7

101

577

A06AD11

ATC

lactulose; oral

1.3

6.7

664

5401

G43.9

ICD-10 Finland

Migraine, unspecified

1.4

6.7

270

1933

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.3

6.7

510

4020

NF1AT

NOMESCO Finland

Puncture of hip joint with ultrasound guidance

2.8

6.7

110

K92.1

ICD-10 Finland

Melaena

1.4

6.6

239

1676

LX1XE, ,

SPAT

6.4

6.6

LCA98

NOMESCO Finland

Other transluminal endoscopic operation on uterus

2.8

6.6

116

S19

ICPC

Skin injury other

1.5

6.6

190

1275

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

1.5

6.6

214

1471

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

1.8

6.6

536

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

1.8

6.6

507

M15.8

ICD-10 Finland

Other polyarthrosis

1.8

6.6

507

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.5

6.6

180

1195

S60.0

ICD-10 Finland

Contusion of finger(s) without damage to nail

1.6

6.6

162

1051

WX322

NOMESCO Finland

Combined spinal-epidural analgesia in obstetrics

1.9

6.6

379

L30.8

ICD-10 Finland

Other specified dermatitis

1.6

6.6

126

770

C08CA13

ATC

lercanidipine; oral

1.2

6.6

687

5623

IBB03

NOMESCO Finland

Assessment of vocational rehabilitation needs in a mental health context

3.2

6.5

L57

ICD-10 Finland

Skin changes due to chronic exposure to nonionizing radiation

3.3

6.5

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.4

6.5

311

2290

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.2

6.5

989

8409

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

1.4

6.5

255

1817

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.2

6.5

1214

10515

R96

ICPC

Asthma

1.3

6.5

465

3636

CBB10

NOMESCO Finland

Excision of redundant skin of eyelid

1.8

6.5

562

L05

ICD-10 Finland

Pilonidal cyst

6.2

6.4

F31.8

ICD-10 Finland

Other bipolar affective disorders

1.8

6.4

504

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.2

6.4

1262

10976

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

2.2

6.4

221

NDU20

NOMESCO Finland

Removal of internal fixation device from wrist or hand

1.8

6.4

519

ABC26

NOMESCO Finland

Open discectomy of lumbar spine

1.8

6.4

556

MAC01

NOMESCO Finland

Rupture of aminiotic membrane for induction of labor

2.0

6.4

355

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.4

6.4

270

1949

R04.0

ICD-10 Finland

Epistaxis

1.3

6.4

349

2626

KMAK, ,

NOMESCO Finland

0.9

6.4

2524

27391

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

1.9

6.3

356

J01FA15

ATC

telithromycin; oral

1.3

6.3

476

3744

OAA40, ,

SPAT

1.6

6.3

131

816

NHG77

NOMESCO Finland

Arthroplasty of interphalangeal tarsal joint(s)

1.8

6.3

543

N48

ICPC

Neurological, Clarification/discussion RFE/demand

8.1

6.3

K04.09

ICD-10 Finland

Pulpit UNS

1.5

6.3

214

1485

J01CF05

ATC

flucloxacillin; systemic

1.4

6.3

302

2227

IHZ19, ,

SPAT

3.2

6.3

WX120

NOMESCO Finland

Intravenous local anesthesy of arm

1.9

6.3

386

R03BB04

ATC

tiotropium bromide; inhalant

1.3

6.2

452

3539

G03DB01

ATC

dydrogesterone; oral

1.3

6.2

532

4252

H10.8

ICD-10 Finland

Other conjunctivitis

2.2

6.2

237

R06

ICPC

Nose bleed/epistaxis

1.7

6.2

105

621

WX892

NOMESCO Finland

Monitored bed care

1.3

6.2

369

2814

N05CF02

ATC

zolpidem; oral

1.2

6.2

863

7278

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

1.6

6.2

143

916

ZY000

NOMESCO Finland

Hospital inpatient

2.0

6.2

332

OAA32, ,

SPAT

2.4

6.2

162

S97

ICPC

Chronic ulcer skin

1.4

6.2

271

1971

R08

ICPC

Nose symptom/complaint other

1.5

6.1

164

1084

R13

ICD-10 Finland

Dysphagia

1.3

6.1

327

2451

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

1.5

6.1

169

1125

L01

ICPC

Neck symptom/complaint

1.2

6.1

784

6554

S81.9

ICD-10 Finland

Open wound of lower leg, part unspecified

2.2

6.1

219

ZYD01

NOMESCO Finland

Emergency clinic

3.4

6.1

WZA90, ,

SPAT

7.7

6.1

RS132, ,

NOMESCO Finland

7.7

6.1

N06AX12

ATC

bupropion; oral

1.3

6.1

329

2471

N03AG01

ATC

valproic acid; systemic, rectal

1.4

6.1

281

2059

N06AB04

ATC

citalopram; systemic

1.2

6.1

1042

8952

SPAT1265

SPAT

Breathalyser

2.2

6.1

226

R80

ICD-10 Finland

Isolated proteinuria

2.3

6.1

194

C07AA05

ATC

propranolol; systemic

1.2

6.1

1036

8898

QX2XE, ,

SPAT

2.5

6.1

145

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.2

6.1

809

6790

I71.9

ICD-10 Finland

Aortic aneurysm of unspecified site, without mention of rupture

2.0

6.1

327

CS3P4

NOMESCO Finland

Optic nerve head stereophotography

2.2

6.1

220

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.4

6.1

210

1464

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

3.0

6.0

Z04

ICD-10 Finland

Examination and observation for other reasons

1.9

6.0

412

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

1.6

6.0

127

795

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.2

6.0

786

6582

K57

ICD-10 Finland

Diverticular disease of intestine

1.7

6.0

581

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

1.4

6.0

255

1842

S14

ICPC

Burn/scald

1.5

6.0

166

1105

P20

ICPC

Memory disturbance

1.3

6.0

589

4784

R51

ICD-10 Finland

Headache

1.4

6.0

262

1902

D01

ICD-10 Finland

Carcinoma in situ of other and unspecified digestive organs

10.0

6.0

SAA02, ,

SPAT

3.1

6.0

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

2.6

6.0

128

N40

ICD-10 Finland

Hyperplasia of prostate

1.2

6.0

1027

8822

SPAT1310

SPAT

Counselling related to known health issue

0.9

6.0

1369

15461

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

2.2

6.0

208

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

882

872

11.41

307.65

1.3

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

502

557

9.62

307.65

1.2

1.1

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

2554

13458

2.41

250.56

3.7

3.6

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1914

9903

2.28

186.03

3.1

2.8

1.08

1.12

e6/l

0.14

715

5703

(3018095) Leukocytes [#/volume] in Urine

3217

20533

2.04

179.61

4.5

3.8

55.76

93.10

e6/l

3.02

1987

14541

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1775

9237

2.23

167.62

3.3

3.0

2.58

2.49

e6/l

0.12

569

5073

(3015736) pH of Urine

3444

22938

1.98

166.18

3.6

3.3

5.84

5.89

0.32

211

1801

(36304419) Bacteria [Presence] in Urine

2598

15789

2.02

161.86

3.6

3.1

—

(3030467) Casts [#/volume] in Urine by Automated count

2599

16205

1.96

147.05

3.6

3.2

0.44

0.40

e6/l

0.35

1750

12357

(3035350) Ketones [Presence] in Urine by Test strip

3948

28481

1.88

140.39

3.8

3.6

0.00

estimate

3.24

540

5712

(3009261) Glucose [Presence] in Urine by Test strip

3972

28765

1.87

138.92

3.8

3.6

0.01

0.00

estimate

0.22

495

5263

(3021601) Nitrite [Presence] in Urine by Test strip

3937

28457

1.87

138.26

5.3

4.8

0.00

estimate

0.80

518

5416

(3002582) Erythrocytes [#/volume] in Urine

2720

17593

1.89

134.77

3.7

3.3

64.52

83.37

e6/l

0.53

1851

13536

(3003338) MCHC [Mass/volume]

6014

50566

2.31

131.83

23.0

17.8

332.41

332.82

g/l

2.93

5993

50213

(3033658) Prothrombin time (PT) actual/Normal

2304

14944

1.80

107.19

4.6

4.2

87.89

89.87

3.20

2267

14591

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1088

5494

2.16

105.62

2.7

2.4

82.82

38.48

u/l

0.52

959

4713

(3023368) Bacteria identified in Blood by Culture

2344

15353

1.79

105.04

4.8

4.4

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1199

6319

2.08

103.90

1.8

—

(3031040) Bacteria [#/volume] in Urine by Automated count

4764

38162

1.77

102.96

4.8

4.4

1832.34

1547.47

e6/l

0.07

498

(3018418) pH of Serum or Plasma

2485

16732

1.75

100.06

4.2

4.1

7.40

0.29

276

3241

(3002385) Erythrocyte distribution width [Ratio]

5928

51069

2.02

98.40

20.6

16.7

14.22

14.91

9.86

5866

50189

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1164

6309

2.01

92.43

1.7

1.8

—

(3000991) Gas panel - Venous blood

985

5114

2.08

87.70

8.9

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

4266

33917

1.65

86.73

9.7

9.3

4.23

4.09

e9/l

2.95

3419

29601

(3044889) 12 lead EKG panel

4822

40166

1.64

75.67

3.7

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

233

6949

0.31

72.41

4.2

4.4

30.61

32.20

1.54

166

4815

(3019150) Specific gravity of Urine by Refractometry

1862

12437

1.67

72.22

4.1

4.0

1.05

1.02

kg/l

0.50

225

1914

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

6460

58810

2.21

72.16

17.4

14.0

27.94

23.52

mg/l

19.67

5446

46375

(3019198) Lymphocytes [#/volume] in Blood

3813

30348

1.56

69.84

6.3

6.2

1.94

1.95

e9/l

0.02

3029

26900

(3014111) Lactate [Moles/volume] in Serum or Plasma

929

5110

1.94

69.15

7.5

1.39

1.35

mmol/l

0.58

923

4980

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

653

3194

2.15

67.09

4.7

5.2

24.06

24.02

mmol/l

0.13

648

3147

(3011648) Oxygen content in Venous blood

193

491

4.01

67.08

2.2

5.1

10.68

11.21

0.77

193

491

(3001604) Monocytes [#/volume] in Blood

3691

29482

1.53

64.14

6.3

6.1

0.59

e9/l

0.28

2861

25521

(3006315) Basophils [#/volume] in Blood

3691

29551

1.52

62.94

6.3

6.1

0.04

e9/l

0.48

2864

25572

(3000850) Epithelial cells [#/volume] in Urine

1799

12289

1.62

62.24

2.7

2.6

6.35

5.55

e6/l

1.25

1644

11033

(3019550) Sodium [Moles/volume] in Serum or Plasma

6489

59850

2.09

59.12

19.3

16.0

139.33

139.65

mmol/l

18.83

6418

58381

(3021447) Carbon dioxide [Partial pressure] in Venous blood

969

5666

1.82

58.97

4.3

4.6

5.72

5.83

kpa

3.02

949

5507

(3023103) Potassium [Moles/volume] in Serum or Plasma

6502

60023

2.11

58.95

19.5

16.1

3.95

3.97

mmol/l

8.84

6424

58438

(3002032) Base excess in Venous blood by calculation

965

5652

1.82

58.36

4.3

4.7

1.58

1.85

mmol/l

1.53

837

4758

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3678

29733

1.50

57.72

6.4

11.72

11.78

umol/l

0.07

3537

28204

(3013115) Eosinophils [#/volume] in Blood

3760

30556

1.49

57.33

6.6

6.4

0.20

0.19

e9/l

0.08

2956

26860

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1628

11041

1.62

57.25

3.9

3.7

286.22

530.86

ng/l

1.37

1325

8489

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1393

9210

1.64

53.87

1.8

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

5091

44328

1.54

53.52

8.0

7.6

76.96

79.01

u/l

3.12

4913

41824

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3251

26015

1.46

51.27

6.9

6.5

1.20

1.21

mmol/l

16.51

3125

23829

(3021589) Normoblasts [#/volume] in Blood

3271

26229

1.46

50.90

9.0

9.7

0.00

e9/l

1.29

2272

21460

(3037467) Urinalysis macro (dipstick) panel - Urine

4673

40170

1.49

50.41

4.2

—

(40760892) CBC W Ordered Manual Differential panel - Blood

3425

27788

1.45

49.61

6.6

6.7

—

(40758558) Short blood count panel - Blood

2046

15022

1.51

49.24

7.1

—

(3026782) Osmolality of Urine

1645

11627

1.54

46.92

2.8

2.9

547.05

546.53

mosm/kgh2o

0.03

1426

10015

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

300

1242

2.48

45.31

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

300

1242

2.48

45.31

1.3

—

(3007461) Platelets [#/volume] in Blood

6861

65531

2.98

45.11

24.5

20.6

244.66

251.45

e9/l

13.42

6562

63950

(3026361) Erythrocytes [#/volume] in Blood

6863

65580

2.98

44.70

24.5

20.5

4.48

4.51

e12/l

6.45

6542

63820

(3024731) MCV [Entitic volume]

6862

65572

2.97

44.57

24.4

20.5

90.91

90.76

2.09

6830

64723

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3482

28676

1.42

44.52

7.3

7.1

1.21

mmol/l

8.90

3190

24432

(3000963) Hemoglobin [Mass/volume] in Blood

6863

65596

2.97

44.37

24.6

20.7

135.16

135.84

g/l

3.53

6834

64737

(3035941) MCH [Entitic mass]

6861

65568

2.95

44.35

24.4

20.5

30.31

30.26

1.60

6831

64716

(3010813) Leukocytes [#/volume] in Blood

6861

65580

2.95

44.10

24.5

20.6

6.96

6.75

e9/l

6.98

6537

63796

(3009542) Hematocrit [Volume Fraction] of Blood

6854

65483

2.89

44.02

25.0

20.7

40.20

40.49

1.30

6547

61508

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

4459

38542

1.43

42.43

3.3

3.1

—

(3013512) EKG study

1125

16300

0.63

42.35

3.5

3.9

—

(3019225) pH of Specimen

241

5604

0.41

42.18

4.4

4.3

—

(3002030) Lymphocytes/100 leukocytes in Blood

3467

28700

1.41

42.08

6.5

6.4

27.81

28.27

1.54

3350

26977

(3022096) Basophils/100 leukocytes in Blood

3274

26893

1.41

41.24

6.5

6.4

0.67

0.18

3152

25127

(3018010) Neutrophils/100 leukocytes in Blood

3417

28288

1.40

41.05

6.4

6.2

57.03

56.84

0.40

3297

26571

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

499

2647

1.95

40.45

2.8

3.5

1.22

1.26

0.30

499

2629

(3019069) Monocytes/100 leukocytes in Blood

3371

27901

1.40

40.23

6.7

6.6

8.68

8.59

0.94

3248

26168

(3024354) Oxygen [Partial pressure] in Venous blood

774

4716

1.72

39.91

3.6

4.2

4.69

4.70

kpa

0.03

749

4572

(3024928) Oxygen saturation in Venous blood

287

1235

2.38

39.80

2.8

4.3

—

(3006504) Eosinophils/100 leukocytes in Blood

3350

27740

1.40

39.64

6.5

6.3

2.84

2.87

0.27

3232

25975

(3013826) Glucose [Moles/volume] in Serum or Plasma

4014

34272

1.40

39.53

5.6

4.9

6.65

6.67

mmol/l

0.32

3846

31993

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

487

2583

1.95

39.47

2.8

3.4

0.57

0.65

5.51

487

2567

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

6593

62342

1.92

37.91

11.3

10.3

26.84

26.74

u/l

0.14

6510

60202

(3002173) Hemoglobin [Mass/volume] in Arterial blood

849

5389

1.65

37.38

9.3

8.3

122.34

122.06

g/l

0.14

833

5238

(3003396) Base excess in Arterial blood by calculation

986

6527

1.59

36.53

8.6

7.5

0.56

1.05

mmol/l

3.88

812

5135

(3027801) Oxygen [Partial pressure] in Arterial blood

986

6535

1.59

36.33

8.6

7.5

12.50

12.41

kpa

0.20

952

6237

(3024561) Albumin [Mass/volume] in Serum or Plasma

3008

24698

1.38

36.28

5.1

35.68

35.64

g/l

0.14

2881

23003

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

985

6535

1.59

36.12

8.6

7.5

4.99

5.10

kpa

3.54

951

6241

(3026008) Bacteria identified in Urine by Culture

2192

17123

1.41

35.42

2.9

3.0

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2816

23010

1.37

34.39

2.0

94.64

95.67

pmol/l

0.56

1414

12145

(3016502) Oxygen saturation in Arterial blood

891

5840

1.60

34.27

9.0

7.9

96.02

95.58

1.67

860

5622

(3004119) Hemoglobin [Mass/volume] in Venous blood

588

3463

1.76

34.00

3.1

3.9

131.34

129.40

g/l

1.26

581

3372

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

989

6741

1.54

31.90

3.0

3.1

6.82

8.11

umol/l

1.61

895

5850

(3020779) Urea [Moles/volume] in Serum or Plasma

821

5384

1.59

31.34

6.6

8.3

9.95

9.45

mmol/l

1.12

797

5153

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

5881

54488

1.48

31.30

16.0

12.9

82.68

82.60

ml/min/173m2

0.10

4653

44909

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1375

10125

1.44

30.09

3.0

3.1

2.45

mmol/l

0.58

1252

8834

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

515

3027

1.76

29.89

10.9

9.7

24.13

24.29

mmol/l

0.56

504

2941

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1261

9161

1.46

29.59

2.1

2.4

29.94

29.90

0.10

1242

8885

(3013707) Erythrocyte sedimentation rate by Westergren method

4786

42996

1.35

28.91

4.2

4.1

12.42

11.73

mm/h

2.70

4593

39880

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2360

19245

1.34

27.35

3.5

3.3

30.73

34.86

u/l

3.03

2290

18247

(3052851) Hemolysis interference index of Serum or Plasma

331

1749

1.94

27.04

3.1

3.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

283

1438

2.01

25.88

2.5

2.2

0.00

g/l

-0.00

265

1336

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

509

3125

1.68

25.13

9.9

10.4

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

283

1459

1.98

24.85

2.5

2.2

0.00

g/l

0.38

265

1339

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

5751

53616

1.40

24.54

4.6

1.89

2.13

mu/l

1.95

5517

49311

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

6151

58086

1.47

24.01

4.7

4.8

2.71

2.76

mmol/l

4.15

5921

53784

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2115

17227

1.32

23.94

2.1

2.2

248.67

224.68

u/l

0.35

2021

16172

(3021960) Folate [Moles/volume] in Serum or Plasma

1646

12943

1.35

23.60

1.6

1.5

20.60

20.30

nmol/l

0.36

1494

11129

(40761535) Cells panel - Urine sediment

690

4645

1.54

23.15

3.6

3.5

—

(3007853) Bacteria identified in Skin by Aerobe culture

968

6980

1.45

23.12

1.8

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1633

12871

1.35

22.95

1.8

1.9

1.14

1.23

mg/l

0.53

1280

9798

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

528

3347

1.62

22.95

1.7

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

293

1578

1.89

22.61

2.5

2.2

0.01

0.03

g/l

1.19

275

1452

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

296

1621

1.86

21.70

2.4

2.1

37.48

37.78

g/l

0.39

272

1431

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

133

535

2.51

21.49

4.0

3.7

—

(3029937) Albumin [Presence] in Urine by Test strip

1879

15288

1.31

20.83

4.4

4.0

0.00

estimate

0.11

491

5213

(3028707) Methadone [Presence] in Urine by Screen method

210

1041

2.05

20.62

3.1

2.9

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

406

2504

1.66

19.65

1.1

70.84

2.45

u/ml

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

605

4142

1.50

18.63

1.7

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

307

1786

1.75

18.44

2.7

2.3

0.83

0.88

g/l

0.08

280

1548

(3020891) Body temperature

371

2280

1.66

18.21

5.6

4.8

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

4851

44728

1.27

18.19

3.9

14.69

14.74

pmol/l

0.60

4610

40813

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

316

1864

1.73

18.07

1.4

1.3

—

(1761868) Lipid panel - Serum or Plasma

1730

20776

0.78

17.58

2.6

2.8

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

325

1948

1.70

17.54

2.5

2.3

10.12

10.19

g/l

0.13

301

1744

(3022217) INR in Platelet poor plasma by Coagulation assay

3002

26310

1.24

17.25

17.0

14.6

1.26

1.25

inr

0.15

710

7729

(3023420) DNA double strand Ab [Units/volume] in Serum

135

605

2.25

17.21

1.5

1.4

19.83

23.93

iu/ml

—

(4200892) Spirometry reversibility

587

4059

1.49

17.19

1.5

1.4

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

2245

19045

1.26

17.17

3.9

3.4

2.36

2.35

mmol/l

0.76

2102

16790

(3044941) Cell count panel - Synovial fluid

176

885

2.01

16.69

1.4

—

(3037522) Nuclear Ab [Titer] in Serum

1031

7928

1.35

16.43

1.4

1.3

437.14

516.00

titre

0.63

168

1612

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

5878

55768

1.33

16.38

4.2

4.4

5.97

5.92

mmol/l

2.65

5633

51045

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

304

2.75

16.28

1.5

3.4

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

5999

57133

1.34

15.89

4.2

4.3

4.56

4.65

mmol/l

9.34

5779

53213

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

672

4840

1.43

15.86

2.4

2.3

6.77

7.43

ug/l

0.36

614

4259

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2535

21968

1.24

15.67

4.1

3.7

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2704

23637

1.23

15.30

2.4

2.3

75.19

76.62

nmol/l

2.08

2578

21329

(3022948) Iron [Moles/volume] in Serum or Plasma

1153

9112

1.32

15.12

2.7

2.6

12.79

13.23

umol/l

1.28

1108

8546

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

482

3289

1.50

15.04

1.4

1.5

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

157

788

2.01

15.00

1.6

1.5

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1854

15581

1.26

14.92

2.9

3.1

1203.24

1364.56

ng/l

1.04

1656

13318

(3024891) Influenza virus A+B Ag [Presence] in Specimen

267

1595

1.70

14.63

1.1

1.2

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

381

2489

1.56

14.55

1.5

18.67

13.72

u/ml

0.21

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2885

25487

1.22

14.48

3.0

2.9

120.52

125.59

ug/l

0.56

2785

23684

(4094501) Cardiovascular stress test using bicycle ergometer

264

1584

1.69

14.24

1.1

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

314

1972

1.62

14.18

2.6

2.3

3.11

2.94

g/l

2.34

290

1784

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1007

7884

1.32

14.04

2.7

22.13

22.86

0.90

915

6780

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

218

1247

1.77

13.96

1.2

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

329

2103

1.59

13.82

2.5

2.2

3.80

3.67

g/l

0.59

305

1914

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

329

2106

1.59

13.74

2.5

2.2

7.32

7.38

g/l

0.32

305

1915

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1215

9789

1.29

13.67

1.3

37.24

31.14

iu/ml

0.56

335

3058

(3016879) Cocaine [Presence] in Urine

337

2175

1.58

13.59

2.5

2.2

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

328

2104

1.59

13.58

2.5

2.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

292

1829

1.62

13.35

2.6

2.3

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

986

7749

1.32

13.33

6.3

6.7

1.07

1.06

mmol/l

0.82

942

7253

(3036180) Methadone [Presence] in Urine

290

2.60

13.31

1.8

3.3

—

(3022313) Gas panel - Capillary blood

177

3091

0.56

13.02

4.5

5.2

—

(3027944) Amphetamines [Presence] in Urine

350

2302

1.55

12.99

2.5

2.2

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

108

2194

0.48

12.95

2.1

1.8

—

(3044640) Blood type and Crossmatch panel - Blood

2148

18584

1.22

12.82

2.4

—

(3042936) Bacteria identified in Isolate by Culture

1033

8226

1.30

12.63

2.1

2.0

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1169

9477

1.28

12.42

3.4

3.9

0.80

0.82

mmol/l

2.88

1108

8900

(3027008) Opiates [Presence] in Urine

351

2346

1.52

12.12

2.4

2.0

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

5558

52832

1.25

12.10

5.4

5.6

39.76

39.57

mmol/mol

0.83

5354

49075

(3015171) Extractable nuclear Ab [Units/volume] in Serum

337

2236

1.53

12.04

1.2

0.29

1.03

u/ml

2.80

205

(3000764) Benzodiazepines [Presence] in Urine

349

2335

1.52

11.99

2.4

2.2

—

(3028300) Cannabinoids [Presence] in Urine

351

2352

1.52

11.98

2.5

2.2

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1772

15118

1.23

11.95

1.6

1.46

1.38

mmol/l

2.05

1593

12767

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

636

4763

1.37

11.85

2.3

3.0

207.37

190.30

ng/l

0.44

588

4324

(3018405) Lactate [Moles/volume] in Arterial blood

309

2019

1.55

11.84

5.2

3.8

1.31

1.38

mmol/l

0.61

303

1986

(46235355) HIV 1 and 2 tests - Meaningful Use set

1342

11147

1.25

11.53

1.8

1.9

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

132

2399

0.54

11.19

2.3

1.9

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

879

6964

1.30

11.09

9.0

6.7

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

375

2596

1.47

10.92

1.6

1.7

1.45

1.53

g/l

1.03

336

2238

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

303

2010

1.53

10.86

3.7

3.6

253.21

2812.97

u/ml

1.15

257

1727

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

163

2769

0.58

10.86

4.8

5.4

24.33

24.68

mmol/l

1.13

152

2601

(3020630) Protein [Mass/volume] in Serum or Plasma

614

4637

1.35

10.83

2.8

2.6

65.84

66.47

g/l

1.20

579

4233

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1040

8443

1.27

10.81

2.7

2.6

2.29

2.34

g/l

2.05

997

7863

(3021788) Differential panel - Synovial fluid

174

1007

1.75

10.79

1.5

—

(40761511) CBC panel - Blood by Automated count

6324

61240

1.32

10.70

13.0

13.1

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

248

1578

1.59

10.69

1.6

1.4

9.40

14.01

iu/ml

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1697

14562

1.22

10.60

2.2

2.3

2.71

2.91

mg/l

2.82

1487

12513

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1658

14201

1.22

10.55

2.2

2.4

—

(3019060) Gas panel - Arterial blood

510

3762

1.38

10.44

5.2

5.0

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

5907

56748

1.25

10.43

4.0

4.3

1.41

1.45

mmol/l

10.70

5675

52565

(3023511) Choriogonadotropin [Units/volume] in Urine

192

1157

1.68

10.30

1.4

1.3

—

(36660697) Celiac disease serology panel - Serum

636

4867

1.34

10.27

1.2

—

(3048689) Calprotectin [Mass/mass] in Stool

911

7335

1.28

10.09

2.1

2.4

125.68

131.52

ug/g

0.23

769

5842

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

204

1260

1.64

9.96

1.3

1.4

233.26

270.05

u/ml

1.56

147

763

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

825

6574

1.29

9.92

4.4

4.3

239.43

243.96

u/l

0.41

798

6231

(3036048) Francisella tularensis Ab [Titer] in Serum

141

2.99

9.80

1.3

1.1

293.33

588.57

titre

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

484

3578

1.38

9.78

8.1

7.0

24.33

24.54

mmol/l

0.72

462

3400

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

277

1851

1.52

9.63

1.7

1.6

1.16

1.18

g/l

0.88

262

1745

(3009508) Creatinine [Moles/volume] in Urine

2063

18164

1.19

9.62

3.4

3.3

7.67

7.69

mmol/l

0.07

1871

15451

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

269

1790

1.52

9.55

1.7

1.6

0.23

g/l

0.96

256

1686

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

514

3852

1.36

9.53

2.2

2.0

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

255

1692

1.53

9.18

4.1

3.3

47.33

88.29

mg/l

0.65

220

1374

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

254

1691

1.52

9.01

4.1

3.3

37.56

55.07

mg/l

1.17

219

1373

(3021879) Hepatitis B virus core Ab [Presence] in Serum

582

4485

1.32

8.96

1.5

1.4

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1107

9237

1.23

8.92

1.3

1.2

6.95

11.80

u/ml

2.28

409

3575

(3000475) Leukocytes [#/volume] in Synovial fluid

209

1342

1.57

8.74

1.6

12919.23

14281.85

e6/l

0.20

126

975

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

208

1339

1.57

8.61

1.3

1.4

—

(3036489) Thrombin time

330

2341

1.43

8.51

2.2

2.7

21.16

21.63

0.80

309

2048

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

246

1649

1.51

8.48

4.1

3.3

2.04

2.77

ratio

0.27

135

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

190

1204

1.59

8.42

1.4

1.6

106.50

113.74

u/ml

0.41

234

(3026493) Urate [Moles/volume] in Serum or Plasma

1741

15305

1.18

7.99

2.9

2.7

3010.97

4435.47

umol/l

0.90

1604

13493

(3009343) pH of Capillary blood

294

4101

0.70

7.89

3.9

4.9

7.42

7.41

0.40

452

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

272

1890

1.46

7.86

2.6

3.3

3.85

3.49

g/l

3.42

263

1794

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

203

1328

1.54

7.86

1.5

1.6

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

299

4148

0.71

7.78

3.9

4.9

4.98

5.14

kpa

3.10

286

3955

(3011288) Drugs identified in Urine by Screen method

232

1568

1.49

7.72

4.1

3.1

—

(3004588) Protein electrophoresis panel - Serum or Plasma

488

3756

1.32

7.59

2.7

2.3

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

284

2006

1.43

7.53

1.3

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

123

719

1.72

7.50

1.2

1.3

31.35

44.89

u/ml

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

176

1129

1.57

7.45

1.8

1.6

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

288

3971

0.71

7.23

3.8

4.9

1.43

1.65

mmol/l

0.54

197

2954

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2994

27598

1.15

7.15

2.6

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

588

4678

1.28

7.14

2.5

2.6

64.02

67.10

ml/min/173m2

1.15

223

1849

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

259

1823

1.44

7.03

2.4

3.1

183.66

188.32

0.42

252

1738

(3006184) Hemoglobin [Mass/volume] in Capillary blood

196

1306

1.51

7.02

1.9

2.3

134.61

129.71

g/l

1.87

114

948

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

690

0.35

6.91

1.6

2.1

19.40

24.27

mg/l

—

181

(3017143) Hepatitis C virus Ab [Presence] in Serum

837

6964

1.23

6.86

1.7

1.6

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

178

1176

1.53

6.65

1.2

50.04

41.72

u/ml

0.21

122

(3016650) Hepatitis A virus Ab [Presence] in Serum

155

993

1.57

6.65

1.1

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

280

2028

1.40

6.49

2.3

3.3

91.37

91.60

0.06

275

1953

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1739

15513

1.16

6.42

4.1

22.36

21.83

0.66

792

7336

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1026

8764

1.20

6.41

1.4

1.5

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

237

1671

1.43

6.41

1.2

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

197

2.29

6.32

2.0

2.3

65.91

68.31

ug/l

0.06

191

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1278

11141

1.18

6.32

1.6

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

236

2.17

6.28

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

318

0.22

6.26

1.1

1.3

—

(3023410) Appearance of Cerebral spinal fluid

105

620

1.70

6.25

2.1

2.0

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

396

3047

1.32

6.22

2.1

1.9

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

238

1691

1.42

6.18

1.2

—

(3005033) Fetal Nuchal fold Thickness US

179

1204

1.50

6.18

1.3

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

183

1238

1.49

6.14

1.4

1.5

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

382

1.89

6.11

1.2

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1036

11982

0.84

6.10

1.6

1.7

4227361.86

31900250.12

pmol/l

4.30

899

10022

(3047352) Trisomy 18 risk [Likelihood] in Fetus

179

1209

1.49

6.06

1.4

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

448

1.82

6.05

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

448

1.82

6.05

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

449

1.81

6.00

1.2

1.1

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1338

11763

1.17

5.93

1.6

1.5

2.34

2.39

g/l

0.43

743

7130

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

451

1.80

5.92

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

451

1.80

5.92

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

452

1.80

5.88

1.2

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

195

1350

1.46

5.85

1.8

1.6

22.97

22.74

e6/l

0.01

145

1028

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

195

1350

1.46

5.85

1.9

1.7

1596.36

1179.18

e6/l

0.27

149

1092

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

270

1983

1.37

5.80

2.4

2.3

424.16

613.43

ug/l

0.64

260

1868

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

213

1503

1.43

5.77

1.9

1.8

—

(42529406) Shigella sp [Presence] in Stool by Culture

236

1702

1.40

5.66

1.3

1.2

—

(3029075) Extractable nuclear Ab panel - Serum

176

2.28

5.59

1.1

—

(3045788) Cell count panel - Pleural fluid

497

1.74

5.57

1.5

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

267

1976

1.36

5.49

3.1

4.0

0.30

0.34

u/ml

1.46

139

1131

(4146454) Self-monitoring of blood glucose

601

0.38

5.48

3.0

2.7

—

(3049717) Cytology report of Urine Cyto stain

277

2065

1.35

5.44

2.4

2.6

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

211

2.14

5.41

1.2

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

114

717

1.60

5.37

1.5

1.6

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

114

717

1.60

5.37

1.5

1.6

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

175

1212

1.45

5.28

1.3

1.5

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

210

1504

1.41

5.27

1.3

1.4

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

283

2132

1.34

5.20

1.7

1.9

—

(3012516) Albumin [Mass/volume] in Urine

1835

16644

1.14

5.17

3.3

318.72

390.15

mg/l

0.33

1267

10803

(3027945) Reticulocytes/100 erythrocytes in Blood

767

6512

1.20

5.10

2.8

1.82

1.75

0.82

729

5804

(40768797) Stomach Pathology biopsy report

916

7916

1.18

4.98

1.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

264

1987

1.34

4.90

1.6

1.8

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

494

1.69

4.89

1.1

1.2

146.67

155.92

titre

0.04

(3000570) Elastase.pancreatic [Mass/mass] in Stool

233

1722

1.36

4.87

1.5

1.4

261.96

278.60

ug/g

0.59

138

982

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

447

3610

1.25

4.85

3.3

4.47

4.51

pmol/l

0.34

411

3201

(3027273) Bicarbonate [Moles/volume] in Venous blood

345

2701

1.29

4.83

3.3

3.7

24.50

25.22

mmol/l

4.05

336

2612

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

105

666

1.58

4.82

1.2

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

658

5539

1.21

4.80

2.4

0.22

0.21

g/l

1.60

626

5178

(3017446) Testosterone [Moles/volume] in Serum or Plasma

568

4715

1.22

4.78

2.6

2.2

11.89

12.64

nmol/l

1.38

516

4230

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

424

1.73

4.71

1.6

1.8

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

308

1.86

4.67

1.3

1.7

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

308

1.86

4.67

1.3

1.7

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

150

1035

1.46

4.66

1.4

1.5

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

571

1.62

4.63

1.4

17413.54

69798.80

e6/l

2.51

343

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

136

928

1.47

4.49

1.3

1.4

—

(3005322) IgE [Units/volume] in Serum or Plasma

462

3780

1.24

4.48

1.3

269.25

227.66

u/ml

0.40

435

3494

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

144

994

1.46

4.48

1.1

—

(3000494) Fungus identified in Specimen by Culture

801

6908

1.18

4.46

1.4

1.5

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

3.27

4.45

1.7

2.6

—

(3014271) Vancomycin [Susceptibility]

276

0.29

4.35

3.3

2.9

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

371

2974

1.26

4.33

1.4

1.3

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

260

1992

1.32

4.32

1.5

1.6

328.00

290.26

titre

—

(3023199) Leukocytes [#/volume] in Pleural fluid

638

1.56

4.29

1.4

1.5

1271.00

2303.01

e6/l

2.04

474

(3006922) Hepatitis E virus Ab [Presence] in Serum

417

1.68

4.17

1.0

1.1

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

637

1.54

4.10

2.4

2.3

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

644

5495

1.19

4.08

2.2

2.3

373.71

368.98

nmol/l

0.20

598

5055

(3006653) Thiamine [Moles/volume] in Blood

286

1.82

4.08

1.2

1.3

138.35

135.62

nmol/l

0.19

286

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1047

9291

1.15

4.01

1.7

1.6

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

2.93

3.99

1.6

1.70

1.55

mg/l

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

2.93

3.99

1.6

1.30

0.85

mg/l

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

2.93

3.99

1.6

1.25

0.97

mg/l

0.13

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

2.93

3.99

1.6

3.44

3.68

mg/l

0.04

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

2.93

3.99

1.6

2.07

1.40

mg/l

0.21

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

2.93

3.99

1.6

0.44

2.16

mg/l

1.62

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

2.93

3.99

1.6

2.49

2.83

mg/l

0.06

(3035880) pH of Pleural fluid

297

1.79

3.93

1.1

1.4

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

387

1.68

3.90

1.0

1.1

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

2.88

3.88

1.6

0.68

1.09

mg/l

0.37

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

388

1.68

3.87

1.3

1.5

13.11

12.62

u/l

0.21

373

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

117

801

1.47

3.86

1.2

1.3

0.57

0.62

nmol/l

0.89

110

770

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

389

1.68

3.84

1.0

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

274

2153

1.28

3.81

1.8

1.6

319.98

298.15

mu/l

0.51

260

1945

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

207

0.24

3.78

1.2

1.9

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

166

2.05

3.78

1.3

1.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

133

937

1.43

3.78

1.2

3.10

4.31

u/ml

1.26

403

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

272

1.81

3.76

3.8

3.6

—

(3037756) Immunofixation for Serum or Plasma

155

1123

1.39

3.75

1.7

1.6

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

511

4306

1.20

3.74

4.2

94.51

89.51

ng/l

0.47

478

3735

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

117

809

1.45

3.68

1.2

1.3

0.26

0.28

nmol/l

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

141

1009

1.40

3.68

1.6

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

141

1009

1.40

3.68

1.6

1.7

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1237

11167

1.13

3.64

2.7

2.9

0.79

0.75

ug/l

0.36

876

7284

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

284

3542

0.79

3.61

1.4

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

834

7339

1.15

3.60

1.8

1.52

1.46

1.41

767

6462

(3009466) Valproate [Moles/volume] in Serum or Plasma

124

872

1.43

3.58

4.9

5.2

347.48

369.31

umol/l

0.98

109

758

(3012441) Differential panel - Pleural fluid

546

1.54

3.57

1.4

1.5

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

183

1374

1.34

3.56

1.8

1.5

3.74

3.76

mmol/l

0.10

178

1280

(3020682) Albumin/Creatinine [Ratio] in Urine

1887

17472

1.11

3.53

3.7

3.9

13.23

10.48

mg/mmol

0.88

1255

11252

(3000492) Spirometry study

669

5800

1.17

3.52

1.5

1.4

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

106

726

1.47

3.52

1.2

1.3

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

134

959

1.40

3.51

1.2

1.71

4.09

u/ml

3.13

306

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1953

18123

1.11

3.50

2.7

2.6

67.26

63.13

u/l

0.14

1836

16776

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

138

994

1.40

3.49

3.2

3.9

2105.00

1816.39

u/ml

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

217

1676

1.30

3.47

1.3

—

(21494890) Protein electrophoresis panel - 24 hour Urine

574

1.52

3.47

2.1

2.0

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

534

1.54

3.47

1.3

1.31

1.52

nmol/l

0.95

481

(3013139) Helicobacter pylori Ag [Presence] in Stool

455

3822

1.20

3.46

1.2

—

(40761536) Microorganisms panel - Urine sediment

420

5001

0.83

3.43

4.1

3.9

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

5618

54848

1.12

3.42

3.7

3.9

1.34

1.30

mmol/l

2.87

5369

50425

(3045424) Erythrocytes [Presence] in Urine

996

0.63

3.39

1.3

1.5

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

448

5295

0.83

3.38

1.7

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

342

1.67

3.38

1.2

1.1

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

238

1869

1.28

3.37

2.3

2.7

—

(3020961) Endomysium IgA Ab [Titer] in Serum

350

2876

1.23

3.34

1.1

123.33

185.63

titre

—

(4034850) Laboratory test

233

1827

1.28

3.34

10.0

9.6

—

(3022145) Colonoscopy Study observation

732

6419

1.16

3.33

1.4

1.3

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

161

1.99

3.32

1.3

1.4

116.42

128.24

nmol/l

0.20

119

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

232

1.81

3.31

2.8

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

223

1745

1.29

3.25

1.5

—

(3025941) Bacteria identified in Stool by Culture

396

3307

1.21

3.23

1.3

1.2

—

(3004616) Nuclear Ab [Presence] in Serum

685

0.57

3.21

1.1

1.3

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

575

6621

0.86

3.18

1.6

1.7

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1443

13247

1.11

3.15

1.3

1.74

1.93

u/ml

0.18

362

3433

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

167

1265

1.33

3.11

5.7

6.4

1165.40

1710.72

iu/ml

0.16

188

(3023520) Reticulocytes [#/volume] in Blood

563

4871

1.17

3.07

2.7

70.59

69.51

e9/l

0.19

333

3655

(3000060) B lymphocytes [#/volume] in Blood

231

1.78

3.06

3.0

2.5

203.91

360.15

e6/l

0.97

132

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

352

1.62

3.06

1.2

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

352

1.62

3.06

1.2

1.5

5.29

6.65

u/l

1.31

301

(3035933) Granulocytes/100 leukocytes in Blood

217

1.80

3.03

1.5

1.3

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.58

3.03

1.2

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

198

1542

1.29

3.02

1.8

1.5

522.41

519.49

mg/l

0.03

193

1455

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

771

0.61

3.00

1.3

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

3.55

2.98

1.2

1.3

41.83

34.11

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.35

2.97

1.6

1.8

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

443

1.54

2.93

1.3

—

(3038026) Centromere Ab [Units/volume] in Serum

445

0.49

2.90

1.1

1.2

—

44.35

—

(3002256) Pathology report gross observation

836

7471

1.13

2.90

1.3

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

592

1.46

2.86

1.4

1.5

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

201

1582

1.28

2.85

1.2

2.98

39.82

u/ml

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

321

1.62

2.82

1.5

1.6

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

280

2294

1.23

2.80

2.2

2.0

1.80

2.44

ug/l

0.57

257

2047

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

229

1835

1.26

2.80

1.4

1.6

18.22

4.16

iu/ml

0.52

384

(3032743) Legionella sp IgG Ab [Presence] in Serum

3.33

2.80

1.0

—

(3013336) Amino acids [Identifier] in Serum or Plasma

3.08

2.76

1.8

3.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

3.24

2.72

1.0

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

434

0.50

2.71

1.1

1.2

—

43.69

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

737

0.62

2.70

1.5

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.59

2.69

1.3

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

148

1128

1.32

2.69

1.1

0.51

1.10

u/ml

1.95

521

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

381

1.55

2.67

1.2

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

430

0.51

2.65

1.1

1.2

—

72.82

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

167

1299

1.29

2.62

1.1

1.17

2.26

u/ml

1.95

110

690

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

2.65

2.61

1.0

161.46

164.63

g/l

0.32

(3005988) Vibrio sp identified in Specimen by Organism specific culture

743

0.63

2.61

1.6

1.5

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

403

4693

0.85

2.61

4.0

4.1

1.22

1.23

mmol/l

0.49

359

4113

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

384

1.54

2.59

1.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

262

0.38

2.58

2.7

2.4

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

199

1.76

2.58

1.4

265.49

124.50

nmol/24h

0.36

199

(3010726) Horse dander IgE Ab [Units/volume] in Serum

141

1075

1.32

2.57

1.1

2.89

1.60

u/ml

0.74

573

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

740

0.63

2.57

1.6

1.5

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

220

1775

1.25

2.57

1.8

1.7

—

(3044927) Protein electrophoresis panel - Urine

540

0.57

2.55

1.1

1.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2062

19425

1.09

2.55

4.8

4.7

3.73

2.88

ug/l

0.36

1922

17522

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

187

1483

1.27

2.53

1.3

1.4

—

(3001019) Free T4 and TSH panel - Serum or Plasma

244

2963

0.82

2.52

1.7

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

748

0.64

2.52

1.5

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

3.23

2.51

1.0

1.1

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

187

1486

1.26

2.50

1.3

1.4

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

611

0.60

2.49

3.4

52.72

56.57

0.55

517

(3016018) Differential panel - Cerebral spinal fluid

669

1.39

2.48

1.8

1.7

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

187

1490

1.26

2.45

1.3

1.4

—

(3003434) Protein [Mass/volume] in Pleural fluid

714

1.38

2.43

1.4

1.5

32.12

32.94

g/l

0.26

645

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

187

1492

1.26

2.42

1.4

—

(3003181) Sodium [Moles/volume] in Urine

132

1007

1.32

2.42

1.3

1.5

55.52

65.69

mmol/l

2.48

107

820

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

200

1611

1.25

2.39

1.4

1.5

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

175

1.77

2.36

1.5

1.4

487.26

420.84

mu/l

0.28

168

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

169

1337

1.27

2.36

1.8

1.9

181.96

200.90

pmol/l

1.72

159

1261

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

179

1426

1.26

2.36

1.6

1.7

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.41

2.36

1.0

1.1

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

412

0.53

2.35

1.1

1.2

—

3.43

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

645

5753

1.13

2.34

4.2

4.1

14.38

27.13

ug/l

1.31

522

4657

(3003888) Timothy IgE Ab [Units/volume] in Serum

149

1164

1.29

2.31

1.1

6.31

5.59

u/ml

0.12

625

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

119

902

1.32

2.30

1.5

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

742

0.66

2.28

1.5

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.12

2.27

1.3

1.0

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

680

6098

1.13

2.27

1.5

1.4

—

(40768806) Pleura Pathology biopsy report

563

1.41

2.25

1.5

1.6

—

(40757494) Bilirubin.total [Moles/volume] in Blood

334

1.53

2.22

2.5

93.40

56.15

umol/l

—

(3000330) Specific gravity of Urine by Test strip

237

2846

0.83

2.22

3.0

3.3

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

150

1180

1.28

2.21

1.1

1.2

12.29

3.82

u/ml

—

(3003694) ABO and Rh group [Type] in Blood

1796

16914

1.08

2.20

1.4

1.5

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

296

1.56

2.17

1.4

26.96

32.71

nmol/l

0.86

266

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

180

1.72

2.17

1.5

1.4

68.42

73.88

0.96

173

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.07

2.16

1.3

1.0

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

253

0.43

2.14

1.0

1.1

—

6.49

—

(3007566) Smooth muscle Ab [Titer] in Serum

200

1637

1.23

2.11

1.3

73.33

147.31

titre

1.03

134

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

283

1.56

2.09

1.7

1.6

10.78

4.57

nmol/l

0.29

226

(3044290) Cell count panel - Cerebral spinal fluid

157

1259

1.25

2.01

1.9

1.6

—

(3017732) Neutrophils [#/volume] in Blood

357

4102

0.86

2.01

2.7

2.8

6.29

5.05

e9/l

0.57

316

3353

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

3.08

2.01

1.1

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

4030

39141

1.07

2.00

3.0

3.2

50.06

47.84

u/l

0.69

3867

36578

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

755

0.69

2.00

1.5

—

(3006598) pH of Arterial cord blood

140

1.79

2.00

1.1

1.0

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

143

1137

1.26

1.97

1.6

1.3

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

209

1.63

1.96

1.1

1.3

0.30

g/l

0.12

166

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

164

1326

1.24

1.96

1.7

1.6

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1076

0.74

1.96

1.3

1.5

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

180

1471

1.23

1.95

1.2

1.3

27.95

6.87

u/ml

0.85

225

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

422

3717

1.14

1.90

1.3

74.43

54.34

au/ml

0.53

205

(40768804) Tissue Pathology biopsy report

2452

23461

1.07

1.90

2.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

267

1.54

1.88

1.3

2.3

119.48

148.32

umol/l

0.29

145

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

459

4070

1.14

1.88

2.4

30.17

22.93

au/ml

0.58

313

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

177

1452

1.22

1.86

1.6

1.7

—

(3005719) IgG [Mass/volume] in Serum or Plasma

514

4593

1.13

1.86

3.4

2.7

10.42

10.41

g/l

0.01

482

4201

(3023430) Cat dander IgE Ab [Units/volume] in Serum

107

828

1.30

1.85

1.1

4.23

5.03

u/ml

0.25

358

(3014133) Dog dander IgE Ab [Units/volume] in Serum

114

890

1.28

1.84

1.1

5.30

4.33

u/ml

0.19

441

(3024980) IgG subclass 4 [Mass/volume] in Serum

128

1014

1.27

1.84

1.6

0.95

0.78

g/l

0.61

103

783

(3008898) HLA-B27 [Presence]

240

2030

1.19

1.84

1.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

115

900

1.28

1.83

1.1

123.07

114.76

1.79

109

809

(3023183) Ammonium ion [Moles/volume] in Plasma

162

1320

1.23

1.83

2.5

3.0

36.10

34.68

umol/l

0.33

143

1204

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

167

1.68

1.83

1.1

1.0

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

510

1.38

1.82

1.6

1.5

34.86

30.91

0.35

316

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.57

1.79

1.2

1.3

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

204

1705

1.20

1.79

1.6

1.7

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

176

1450

1.22

1.79

1.2

9.53

5.67

u/ml

0.23

139

(3004775) Volume in Urine collected for unspecified duration

474

0.63

1.77

2.4

2.2

704.96

617.19

0.44

318

(3009214) Lutropin [Units/volume] in Serum or Plasma

221

1864

1.19

1.76

1.5

10.87

9.07

u/l

1.00

168

1488

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

686

1.32

1.75

1.4

1.7

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

2.50

1.73

1.6

1.2

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

2.50

1.73

1.1

2.8

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

447

1.39

1.73

1.2

1.3

—

(3020874) Milk IgE Ab [Units/volume] in Serum

422

1.40

1.72

1.1

1.2

2.25

2.99

u/ml

0.14

168

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

347

1.44

1.72

1.1

6.60

11.78

nmol/l

—

(3039443) Prostate specific Ag panel - Serum or Plasma

1174

0.77

1.70

1.5

1.6

—

(3047189) Immunofixation for 24 hour Urine

266

1.51

1.70

2.2

1.7

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

126

1.75

1.67

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

193

1618

1.20

1.66

1.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

752

6907

1.10

1.66

2.1

—

(3045414) Leukocytes [Presence] in Urine

228

2663

0.85

1.64

1.9

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.03

1.64

1.4

1.3

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

213

1.55

1.61

1.8

2.1

1172.60

4367.66

e6/l

0.43

152

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2220

21274

1.06

1.60

3.5

36.28

70.92

ng/l

0.87

1446

14266

(3024139) IgG subclass 3 [Mass/volume] in Serum

653

1.30

1.59

1.4

0.38

0.41

g/l

0.38

468

(3042111) Morphology [Interpretation] in Bone marrow Narrative

121

972

1.25

1.59

1.9

1.7

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

412

1.39

1.59

1.1

1.2

5.38

3.04

u/ml

0.21

137

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

214

1.54

1.58

1.4

1.2

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

654

1.30

1.58

1.4

2.67

2.87

g/l

0.68

473

(3027135) IgG subclass 1 [Mass/volume] in Serum

654

1.30

1.58

1.4

6.51

6.80

g/l

0.43

471

(1761482) Bacteria [#/volume] in Urine by Culture

110

1372

0.80

1.58

3.3

4.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

1191

0.79

1.55

2.9

3.5

1341.82

611.67

u/ml

0.26

1093

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

771

1.27

1.54

1.4

3.26

4.64

ug/l

1.26

695

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

527

1.33

1.52

1.1

—

(3019309) Folate [Moles/volume] in Red Blood Cells

953

10198

0.92

1.52

1.7

1187.01

1162.86

nmol/l

0.37

783

7719

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

265

1.47

1.52

1.1

207.03

194.84

iu/ml

0.08

265

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

782

1.27

1.52

1.5

1.4

—

(3009871) Measles virus Ab [Titer] in Serum

177

1.58

1.50

1.6

1.7

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

225

1.51

1.50

1.2

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

2.16

1.50

1.0

1.1

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

2.16

1.50

1.0

1.3

—

45.08

—

(3028026) IgM [Mass/volume] in Serum or Plasma

398

3556

1.13

1.50

2.1

1.9

1.14

1.35

g/l

2.92

379

3268

(3030313) Adrenal Ab [Titer] in Serum

2.07

1.48

1.1

—

(40760888) Immunoglobulin light chains.free panel - Serum

153

1272

1.21

1.48

3.9

3.5

—

(3051651) Icteric interference index of Serum or Plasma

384

1.38

1.48

2.9

3.7

—

(3000093) Morphology [Interpretation] in Blood Narrative

557

1.31

1.46

1.2

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

124

1.69

1.46

1.4

2.3

15.42

16.95

umol/l

0.27

124

(40768443) Skin Pathology biopsy report

286

2506

1.15

1.46

1.2

—

(21494755) Public health laboratory ask at order entry panel

525

5757

0.90

1.45

1.3

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

109

877

1.25

1.44

1.2

1.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

735

1.27

1.43

1.2

1.3

426.92

313.26

pmol/l

0.47

632

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

118

1.70

1.40

1.0

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

354

1.39

1.40

2.2

2.5

40.88

40.23

0.09

198

(3023419) Bacteria identified in Sputum by Culture

103

827

1.25

1.40

2.8

2.6

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.25

1.40

1.4

342.33

356.57

umol/24h

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

178

0.50

1.39

6.8

3.2

—

(3044007) Cell count panel - Peritoneal fluid

173

1.56

1.39

1.9

2.0

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

214

1.50

1.37

1.2

1.1

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

2.61

1.36

1.2

1.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

108

875

1.24

1.36

1.2

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

100

804

1.25

1.35

5.2

7.0

10.98

11.60

mg/l

0.63

748

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

306

1.41

1.35

5.5

5.6

40.50

642.46

u/ml

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

531

1.30

1.33

1.2

1.4

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

341

1.38

1.32

10.2

11.8

0.65

0.61

mmol/l

0.77

310

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

745

1.25

1.31

1.1

0.08

0.44

u/ml

2.19

234

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

195

1678

1.17

1.30

1.4

1.3

—

(3049233) Organic acids panel - Urine

2.50

1.30

1.2

1.3

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

193

1.50

1.28

1.8

1.9

6569.14

16005.24

e6/l

0.39

107

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.78

1.28

1.6

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

395

1.34

1.28

2.3

1.6

—

(3034426) Prothrombin time (PT)

226

1.46

1.28

1.1

1.2

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

2.08

1.27

1.0

—

(3000034) Microalbumin [Mass/volume] in Urine

553

0.72

1.27

3.1

66.75

48.33

mg/l

0.14

415

(3011985) Renin [Units/volume] in Plasma

793

1.24

1.27

1.2

1.5

155.00

54.51

mu/l

0.48

705

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

509

1.30

1.26

2.9

2.3

—

(3013727) Leukocytes other/100 leukocytes in Blood

194

1.50

1.26

5.1

3.8

48.52

51.72

0.40

187

(3014051) Protein [Presence] in Urine by Test strip

132

1568

0.84

1.23

2.4

2.6

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

669

6218

1.08

1.19

2.0

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

801

1.23

1.18

2.0

2.6

4.27

8.10

umol/l

3.04

588

(3015076) Soybean IgE Ab [Units/volume] in Serum

358

1.34

1.17

1.1

1.18

2.36

u/ml

0.33

118

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

542

1.27

1.17

3.8

4.7

234.53

68.42

u/ml

0.45

162

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

273

1.39

1.16

1.3

1.2

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

296

2648

1.12

1.15

1.5

1.4

23.70

26.35

iu/l

0.74

240

2228

(4062490) Immunoglobulin typing, IgG

659

1.25

1.15

1.4

—

(40768793) Breast Pathology biopsy report

1199

0.82

1.15

1.3

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.81

1.14

5.6

3.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

113

943

1.20

1.12

1.1

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

344

1.34

1.11

1.2

1.4

4.00

4.70

umol/l

0.75

324

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.26

1.10

1.0

—

(40765096) Chromosome analysis panel by Banding

182

0.55

1.10

1.2

1.1

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

450

1.29

1.09

1.6

1.5

0.97

0.95

g/l

0.16

450

(3042631) Mycobacterium sp identified in Specimen

759

0.79

1.06

2.6

2.9

—

(3052592) Norovirus Ag [Presence] in Stool

105

1.62

1.05

1.6

1.4

—

(3010503) CD19 cells [#/volume] in Blood

372

0.70

1.05

4.1

2.6

0.27

0.35

e9/l

0.16

359

(3002079) Sodium [Moles/time] in 24 hour Urine

262

1.37

1.04

1.1

1.3

156.33

166.95

mmol/24h

0.38

262

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

507

1.26

1.04

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

507

1.26

1.04

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

507

1.26

1.04

1.7

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

131

1118

1.17

1.03

1.7

—

(3023383) Lactate [Moles/volume] in Pleural fluid

163

1.47

1.01

1.0

1.3

4.17

3.32

mmol/l

0.55

146

(3025130) Human papilloma virus identified in Specimen

735

1.21

1.00

1.8

1.7

—

(40768441) Liver Pathology biopsy report

439

1.28

1.00

1.5

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.65

1.00

1.3

1.0

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

147

1.50

1.00

1.7

0.23

0.20

nmol/l

0.13

108

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

147

1.50

1.00

1.0

1.1

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

818

1.20

0.99

1.4

1.5

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

197

1.42

0.99

1.1

1.2

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

172

1.45

0.99

2.3

2.8

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

172

1.45

0.99

2.3

2.8

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

107

1263

0.84

0.98

4.1

3.4

24.87

26.60

mg/l

0.21

776

(3048879) Bone marrow aspiration report

160

0.56

0.97

2.8

2.0

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.80

0.96

1.2

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.85

0.96

4.8

3.8

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

103

868

1.19

0.95

1.3

1.5

0.48

0.38

nmol/l

0.37

690

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.95

0.0

1.2

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

303

2752

1.10

0.94

2.7

3.4

54.49

54.74

u/ml

0.00

295

2653

(3032057) Clostridioides difficile [Presence] in Stool

119

0.50

0.93

1.7

2.0

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

139

1205

1.16

0.92

2.5

1.9

0.79

0.83

nmol/l

0.25

120

1018

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

142

1.48

0.91

1.0

1.2

373.81

280.58

pmol/l

0.73

104

(3011325) HIV 1+2 Ab [Presence] in Serum

2.14

0.91

1.2

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

339

1.30

0.91

1.1

1.2

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

270

2444

1.11

0.91

2.1

1.9

40.06

39.04

u/l

0.30

243

2181

(3045142) Bone marrow Pathology biopsy report

672

1.21

0.90

1.4

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

153

0.59

0.88

1.0

1.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

127

0.55

0.88

1.9

2.5

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

427

3959

1.08

0.86

1.2

116.64

150.03

iu/ml

1.18

150

1454

(3001964) Herpes simplex virus Ag [Presence] in Specimen

186

1.40

0.86

1.6

1.5

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

120

1382

0.87

0.84

1.5

1.6

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

807

1.18

0.83

1.0

1.1

1.50

1.51

g/l

0.11

730

(3017509) Phencyclidine [Presence] in Urine

1.75

0.83

1.1

1.6

—

(3004451) EKG impression Narrative

285

0.70

0.83

1.1

1.3

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

416

1.25

0.82

1.1

5.56

9.76

iu/ml

—

105

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

376

0.74

0.82

1.6

1.4

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

408

1.25

0.81

1.2

1.3

2.12

2.49

u/ml

0.11

227

(1002224) Polysomnography panel

264

2408

1.10

0.79

1.0

1.1

—

(40758358) Immune stain study

0.00

0.79

0.0

1.0

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

294

1.29

0.79

1.7

1.6

1.35

3.10

u/field

1.44

215

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

0.00

0.79

0.0

1.2

—

4147.69

—

(3050129) First trimester maternal screen panel - Serum or Plasma

166

1860

0.89

0.79

1.5

1.4

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.59

0.77

7.1

12.0

4.79

6.00

mmol/l

1.35

(3014148) Varicella zoster virus Ab [Titer] in Serum

805

1.17

0.77

1.2

—

(3017704) Immunofixation for Urine

291

0.72

0.76

2.2

1.6

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

631

1.19

0.75

1.2

—

(40760409) HLA-A [Type] by High resolution

2.08

0.74

1.2

1.0

—

(46236302) HLA-C [Type] by High resolution typing

2.08

0.74

1.2

1.0

—

(40763590) HLA-DQ beta [Type]

2.08

0.74

1.2

1.0

—

(40760410) HLA-B [Type] by High resolution

2.08

0.74

1.2

1.0

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

614

1.19

0.74

1.5

1.8

—

(3019832) Treponema pallidum Ab [Presence] in Serum

620

5866

1.06

0.74

1.6

1.7

—

(3013862) HLA-DP [Type]

2.00

0.72

1.2

1.0

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

263

1.29

0.72

1.7

1.5

3.88

3.51

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

367

0.76

0.72

1.6

1.4

—

(3047181) Lactate [Moles/volume] in Blood

204

1849

1.11

0.71

5.6

6.4

1.29

mmol/l

0.00

178

1620

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

276

0.72

0.71

1.6

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

276

0.72

0.71

1.7

1.5

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

1.55

0.71

1.8

18.61

39.54

pmol/l

1.21

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

117

1.45

0.71

1.4

1.3

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

389

1.23

0.71

1.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

380

1.24

0.71

1.4

—

(3017181) Myelocytes/100 leukocytes in Blood

525

4951

1.06

0.70

4.4

4.3

0.91

0.94

0.07

207

1716

(3039000) Anion gap in Blood

145

1291

1.12

0.70

6.5

7.6

11.49

11.29

mmol/l

0.30

129

1150

(3036071) Salmonella sp Ab [Titer] in Serum

203

1.33

0.70

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

609

1.18

0.70

2.8

3.3

—

(3018572) Chloride [Moles/volume] in Blood

145

1292

1.12

0.69

6.5

7.6

104.81

105.09

mmol/l

0.26

129

1151

(3022806) Fractional oxyhemoglobin in Capillary blood

770

0.84

0.69

2.1

1.9

90.91

89.66

1.42

756

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

409

1.22

0.68

1.3

1.1

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.85

0.68

1.2

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

178

1.35

0.68

1.3

1.1

—

(3022689) Creatine [Moles/volume] in Urine

179

0.67

0.66

1.3

1.5

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

658

0.83

0.66

4.6

3.9

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

193

2117

0.91

0.65

1.7

1.6

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

145

1.38

0.65

1.5

1.4

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.59

0.65

1.0

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.59

0.65

1.6

2.1

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

168

1518

1.11

0.65

2.1

2.0

11.85

11.19

mg/l

0.59

158

1420

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

137

1.39

0.64

1.2

511.80

402.09

ug/l

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

197

1796

1.10

0.64

6.0

6.1

1.47

1.46

mg/l

0.06

183

1675

(40758292) HTLV I+II Ab panel - Serum

104

1.44

0.62

1.4

—

(3037121) Protein [Mass/volume] in Urine

188

2057

0.91

0.62

2.9

3.5

0.28

0.35

g/l

0.61

100

951

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

860

1.14

0.62

1.1

2.99

3.79

u/ml

0.23

392

(21494815) CD4 cells/100 lymphocytes in Specimen

571

1.17

0.62

3.4

2.5

38.98

38.25

0.16

563

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

208

1.30

0.61

1.1

1.2

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

1.67

0.61

1.2

1.5

14.34

27.26

pmol/l

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.60

0.61

2.0

1.7

30.01

41.78

umol/l

—

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

0.00

0.60

0.0

1.5

—

44.17

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

0.00

0.60

0.0

1.0

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

0.00

0.59

0.0

1.2

—

0.20

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

551

0.83

0.58

2.4

2.8

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

648

0.85

0.58

2.7

2.3

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1593

15507

1.03

0.58

3.2

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

382

1.20

0.57

1.2

1.1

—

(3028433) Virus identified in Specimen by Culture

230

0.74

0.57

1.2

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

198

2148

0.92

0.56

1.7

3.89

4.08

mg/l

0.09

150

1561

(3042517) Benzodiazepines panel - Urine

1.50

0.54

7.6

2.6

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

941

0.88

0.54

1.4

1.3

30.55

41.25

u/l

0.45

819

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.54

0.53

1.0

1.1

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

117

1.37

0.52

2.9

2.4

0.90

1.76

mmol/l

1.76

(3024471) HLA-A [Type]

223

1.26

0.52

1.0

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

152

1.32

0.51

1.2

49.64

15.64

u/ml

0.48

114

(3041806) Other cells [#/volume] in Blood by Manual count

203

0.74

0.51

1.5

1.6

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.50

0.51

2.7

3.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

170

1.29

0.51

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

242

1.24

0.50

1.2

1.1

—

(3042733) HLA Ab [Presence] in Serum

224

1.25

0.50

5.0

4.6

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

455

0.83

0.50

1.7

1.6

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

463

1.17

0.49

3.6

2.7

0.23

0.22

e9/l

0.05

388

(3044242) Glucose [Moles/volume] in Arterial blood

279

1.22

0.49

3.4

1.8

—

(3026389) Candida sp identified in Specimen by Organism specific culture

820

1.12

0.49

1.6

1.3

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

144

0.69

0.49

1.0

1.1

—

(40757373) Influenza virus identified in Isolate

110

1.36

0.48

1.3

1.5

—

(3034988) Calcium [Moles/volume] in Capillary blood

145

1.31

0.48

1.5

3.3

1.17

1.19

mmol/l

1.31

138

(40762365) Oxygen content in Arterial blood by calculation

110

0.64

0.48

2.4

2.5

16.14

14.74

ml/dl

—

103

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

738

1.13

0.47

1.3

1.6

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

1.46

0.46

13.7

10.2

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

476

1.16

0.46

3.5

2.7

641.62

520.32

e6/l

0.68

388

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

114

1253

0.91

0.46

1.7

—

(3024932) HLA-DR beta [Type]

219

1.23

0.44

1.2

1.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

109

989

1.10

0.44

3.0

3.1

0.76

0.82

nmol/l

0.70

755

(3012494) Peanut IgE Ab [Units/volume] in Serum

229

1.22

0.43

1.1

1.2

0.78

29.25

u/ml

1.06

139

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

106

962

1.10

0.43

1.1

13.90

11.02

au/ml

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.56

0.42

1.8

1.3

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

217

0.78

0.41

1.1

1.2

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

228

0.79

0.41

2.7

2.4

—

(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

11.64

—

(4212803) Bone marrow aspirate examination

1.36

0.41

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

172

0.75

0.40

2.2

1.5

8.78

8.81

ug/l

0.01

172

(3041354) Potassium [Moles/volume] in Venous blood

667

0.88

0.40

2.6

2.3

3.95

4.07

mmol/l

1.25

656

(3035285) Chloride [Moles/volume] in Venous blood

667

0.88

0.40

2.6

2.3

106.08

105.42

mmol/l

0.53

656

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.1

—

(3008295) Osmolality of Serum or Plasma

625

1.12

0.39

1.6

1.4

283.34

280.06

mosm/kgh2o

0.57

488

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

270

0.81

0.39

1.3

1.1

—

(3028271) Lactate [Moles/volume] in Capillary blood

938

0.90

0.39

2.1

2.0

1.51

1.68

mmol/l

1.73

913

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

711

1.11

0.39

2.7

2.5

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

115

1.30

0.38

1.1

0.60

0.70

umol/24h

—

(3002523) Influenza virus A Ag [Presence] in Specimen

108

989

1.09

0.38

1.2

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

108

989

1.09

0.38

1.2

1.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

124

1.29

0.38

5.4

7.0

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

1.37

0.38

4.9

5.7

32.82

50.01

ug/min

0.63

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

289

1.18

0.37

1.6

2.0

150.56

199.36

ug/min

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.30

0.37

1.4

1.6

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

115

1059

1.09

0.37

1.7

1.8

—

(3000285) Sodium [Moles/volume] in Blood

1.39

0.36

1.2

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

281

1.17

0.36

1.0

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.31

0.35

3.5

1.8

—

(3020393) Adenovirus Ag [Presence] in Stool

123

0.73

0.35

1.3

1.8

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.39

0.35

1.0

1.2

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.37

0.34

7.6

8.4

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.37

0.34

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

181

1.22

0.34

1.3

1.1

—

(3010838) Calcium [Moles/time] in 24 hour Urine

105

968

1.09

0.34

1.4

1.9

4.29

4.92

mmol/24h

1.49

849

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.34

0.34

1.1

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

307

2934

1.05

0.33

2.7

2.9

0.56

0.26

e6/l

1.35

302

2860

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

155

1.23

0.32

1.1

1.2

—

(3004809) Band form neutrophils/100 leukocytes in Blood

977

0.92

0.32

3.5

1.99

1.52

0.42

866

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

257

1.17

0.31

1.5

—

1560833.13

—

(3025159) Blasts/100 leukocytes in Blood

463

4474

1.04

0.31

4.7

4.3

0.47

0.36

0.10

149

1245

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.32

0.30

1.0

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

858

1.08

0.30

1.2

—

(3033799) Differential panel - Peritoneal fluid

193

1.19

0.30

1.7

1.9

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

390

1.13

0.30

1.7

1.6

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

184

1.20

0.30

1.2

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

367

0.87

0.29

1.8

1.5

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

240

2291

1.05

0.29

2.2

5128.52

5236.91

u/l

0.02

898

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.23

0.29

1.1

1.2

2.17

1.66

umol/24h

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

853

1.08

0.28

1.5

1.6

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.28

0.28

3.5

3.4

—

(40765089) Chromosome analysis panel - Blood by G-banded

194

0.82

0.27

1.0

—

(3019977) pH of Arterial blood

318

1.13

0.27

3.9

2.6

7.43

7.42

—

112

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

413

1.11

0.27

1.9

1.5

29.00

19.71

u/ml

0.91

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

672

1.09

0.26

1.4

1.2

—

(3010421) pH of Blood

162

1537

1.05

0.26

4.3

4.6

7.42

0.34

135

1397

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.30

0.26

1.0

1.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

203

0.84

0.26

1.3

1.1

83.83

88.05

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.25

0.25

1.6

—

(3035637) Corticotropin [Mass/volume] in Plasma

838

1.07

0.25

1.4

1.6

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

149

1412

1.06

0.25

1.9

1.8

3.96

4.54

iu/l

0.26

510

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

116

1231

0.94

0.25

1.3

1.5

111.18

161.23

pmol/l

1.24

116

1202

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

148

0.81

0.24

1.2

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.18

0.24

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

137

0.80

0.24

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

137

0.80

0.24

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

137

0.80

0.24

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

137

0.80

0.24

1.0

1.1

—

(3022621) pH of Urine by Test strip

391

3790

1.03

0.24

2.8

2.9

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

426

1.10

0.24

2.2

2.0

1.55

1.77

u/field

0.20

177

(3021901) Oxygen saturation in Capillary blood

100

1061

0.94

0.22

2.6

3.3

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.25

0.22

3.8

5.1

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

242

2332

1.04

0.22

5.3

5.5

0.92

0.89

0.68

225

2179

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

362

1.10

0.21

1.1

1.3

1.51

1.54

g/l

0.20

362

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

273

0.88

0.21

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

410

1.10

0.21

1.1

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.6

—

(40762887) Creatinine [Moles/volume] in Blood

0.00

0.21

0.0

1.1

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.1

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.21

0.0

1.0

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

6.1

—

0.28

—

(3045177) Copper [Moles/volume] in Urine

0.00

0.21

0.0

1.0

—

0.17

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.21

0.0

1.3

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.21

0.0

1.2

—

(21494434) Karyotype in Bone marrow

533

0.92

0.21

1.1

1.2

—

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

0.00

0.21

0.0

9.3

—

55.33

—

(3038385) Creatinine [Moles/volume] in Peritoneal fluid

0.00

0.21

0.0

1.2

—

154.54

—

(40767503) Oxygen content in Capillary blood by calculation

119

1251

0.95

0.20

2.7

2.6

16.88

16.37

0.66

645

(3011412) CD3 cells [#/volume] in Blood

653

1.07

0.20

3.4

2.5

1.27

1.22

e9/l

0.16

572

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

841

0.94

0.20

1.3

7.37

7.21

mmol/l

0.21

751

(3015183) Erythrocyte sedimentation rate

282

0.89

0.20

1.2

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

123

0.81

0.20

1.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

183

1.15

0.20

1.3

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

333

0.90

0.19

1.4

1.6

—

(3051593) INR in Capillary blood by Coagulation assay

249

0.88

0.19

18.5

11.3

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

426

0.91

0.19

1.2

1.3

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

347

1.09

0.18

6.0

6.4

—

(1616796) Gas panel - Central venous blood

125

1306

0.96

0.18

3.6

4.0

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

158

1641

0.96

0.17

1.1

2.85

7.56

u/ml

2.24

212

(3008536) Aspergillus sp Ab [Presence] in Serum

119

1.18

0.17

2.9

2.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.15

0.17

1.3

—

(3002179) Metamyelocytes/100 leukocytes in Blood

464

4541

1.02

0.17

4.3

4.1

0.43

0.69

2.90

165

1501

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

329

3206

1.03

0.17

1.1

—

(3016228) CD19 cells/100 cells in Blood

257

0.89

0.17

2.9

2.1

11.26

8.77

0.31

247

(3027035) Albumin [Mass/time] in 24 hour Urine

0.76

0.17

1.4

1.3

—

577.74

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

0.75

0.17

1.0

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.73

0.17

1.0

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

272

1.10

0.16

1.2

1.1

1801.07

1512.65

miu/ml

0.69

272

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

143

1374

1.04

0.16

1.2

1.3

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.18

0.16

1.0

—

(3024869) Neuronal Ab [Presence] in Serum

101

1.19

0.16

1.0

1.1

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

1.16

0.16

1.0

—

0.94

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

235

0.89

0.16

2.0

2.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

254

1.10

0.15

1.1

1.0

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

0.77

0.15

1.5

1.8

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

467

1.07

0.15

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.15

0.15

1.0

2.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.15

0.15

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

102

976

1.04

0.15

1.0

1.1

122.59

10885.70

iu/ml

0.61

240

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

129

0.85

0.14

1.1

1.3

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.08

0.14

1.1

1.4

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

233

0.90

0.14

2.0

2.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

233

0.90

0.14

2.0

2.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

326

0.92

0.14

1.8

1.5

—

(3029396) Erythrocyte agglutination [Presence] in Blood

160

1.12

0.13

3.2

3.0

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

241

2350

1.03

0.13

5.3

5.4

1.83

1.64

1.62

223

2192

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

228

1.10

0.13

3.2

4.2

7.96

7.86

mg/l

0.02

188

(1617658) Protocol used for examination of sentinel lymph nodes

393

1.07

0.13

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

335

1.07

0.12

1.1

1.26

1.09

u/l

0.54

165

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

200

0.90

0.12

2.8

2.0

—

(3020876) Protein [Mass/time] in 24 hour Urine

638

1.05

0.12

2.7

2.5

1.18

1.39

g/24h

0.23

329

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

177

1817

0.97

0.12

1.5

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

323

0.93

0.12

1.8

1.5

—

(4281824) Cell count and differential, peritoneal fluid

578

0.95

0.11

1.3

1.2

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

209

0.91

0.11

1.2

1.4

—

(40768795) Lymph node Pathology biopsy report

557

0.95

0.11

1.3

1.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

699

0.96

0.11

1.6

1.7

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

102

1054

0.97

0.11

3.7

3.5

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

303

2974

1.02

0.11

2.2

2.4

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

956

1.04

0.10

1.1

1.2

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

250

1.08

0.10

1.2

1.1

435.50

450.95

ng/l

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

198

0.91

0.10

1.3

1.2

78.75

84.94

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

188

1836

1.02

0.10

1.3

201.79

222.69

miu/ml

0.36

834

(3002619) Bacteria identified in Specimen by Culture

125

0.88

0.10

1.1

1.2

—

(3000012) Reticulocyte production index

798

0.96

0.09

2.8

2.1

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

1.09

0.09

1.0

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

493

0.95

0.09

1.2

1.1

327.31

263.89

mg/l

0.92

426

(40768446) Kidney Pathology biopsy report

258

0.93

0.09

2.3

1.8

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

213

1.08

0.09

3.0

3.5

237.22

127.68

au/ml

—

(3043410) Blood group antigens tested for on Red Blood Cells

155

1.10

0.09

2.1

1.8

—

(21494814) CD8 cells/100 lymphocytes in Specimen

247

0.93

0.09

2.9

2.1

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

370

1.05

0.08

20.9

18.1

1234.51

1416.33

nmol/l

0.85

357

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

113

0.88

0.08

1.6

1.5

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

501

0.96

0.08

1.3

1.5

1.58

1.29

promille

0.63

386

(3017569) Oxygen content in Arterial blood

277

0.94

0.08

4.2

2.0

—

(3012898) Urea [Moles/volume] in Urine

0.83

0.08

1.4

1.5

212.00

165.82

mmol/l

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

0.82

0.08

1.2

1.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

511

0.96

0.08

1.2

1.1

52.14

40.17

mg/l

0.92

418

(3007916) DNA double strand Ab [Titer] in Serum

0.81

0.08

1.2

1.4

—

95.32

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

117

1.11

0.08

1.3

1.4

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

0.86

0.07

1.2

1.1

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.82

0.07

1.2

—

(3014891) Appearance of Pleural fluid

0.81

0.07

1.0

1.2

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

296

0.95

0.07

1.9

2.0

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

296

0.95

0.07

1.9

2.0

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

112

0.89

0.07

1.5

1.9

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

589

1.04

0.07

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

392

1.05

0.07

1.4

1.5

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

866

1.03

0.07

1.1

—

(3021440) Promyelocytes/100 leukocytes in Blood

475

4702

1.01

0.07

4.7

4.3

0.10

0.12

0.13

158

1471

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

669

1.03

0.07

1.7

1.6

58.06

57.91

0.01

425

(3005011) Chlamydia sp Ab [Titer] in Serum

0.88

0.06

1.5

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

521

1.04

0.06

1.3

1.4

125016.03

103306.48

e6/l

0.10

363

(3022493) Free Hemoglobin [Mass/volume] in Plasma

265

1.06

0.06

1.3

5.2

97.29

937.85

mg/l

0.48

192

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

128

1.09

0.06

1.1

1.2

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

100

0.90

0.06

1.0

1.1

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

138

1.09

0.06

1.2

1.6

0.38

0.39

ug/l

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

121

0.91

0.06

5.1

6.1

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

121

0.91

0.06

2.5

3.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

266

1.05

0.06

3.7

4.3

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

581

5847

0.99

0.05

3.1

3.4

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

151

0.93

0.05

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

535

0.97

0.05

1.3

1.4

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

138

1400

0.98

0.05

2.3

87.47

101.56

ug/min

0.22

863

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

132

1299

1.02

0.04

1.3

1.4

—

(3012501) Base excess in Blood by calculation

134

1320

1.01

0.04

3.8

4.6

2.50

2.53

mmol/l

0.04

893

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

121

1191

1.02

0.04

4.2

3.8

54.38

57.13

1.76

121

1191

(3040151) Glucose [Moles/volume] in Capillary blood

654

0.98

0.04

11.4

15.6

7.28

7.17

mmol/l

0.08

545

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

151

1.06

0.03

1.2

1.3

36.27

34.60

0.06

100

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

199

0.95

0.03

1.1

—

(4035726) Immunohistochemistry procedure

504

5058

1.00

0.03

1.4

—

(44813793) Dust mix specific IgE antibody measurement

430

0.98

0.03

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

349

0.97

0.02

1.0

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

152

1.05

0.02

2.4

2.8

183.82

144.94

ng/l

0.22

(3024263) Appearance of Synovial fluid

321

1.03

0.02

1.2

1.4

—

(3020650) Glucose [Presence] in Urine

157

0.95

0.01

1.1

1.4

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

382

1.02

0.01

1.1

1.0

232.84

328.61

ng/l

3.78

263

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

717

0.99

0.01

1.1

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

386

0.98

0.00

1.1

1.0

32.73

45.41

ng/l

2.31

261

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

134

1.04

0.00

1.8

1.4

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

484

1.01

0.00

1.5

1.3

346.77

166.95

pmol/l

0.47

484

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

124

0.97

0.00

1.3

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

155

0.97

0.00

6.9

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

110

1.00

0.00

7.9

7.6

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

175

0.97

0.00

6.8

6.7

—

(3006462) Nitrate [Presence] in Urine

283

0.99

0.00

1.5

3.5

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

812

1.00

0.00

1.3

1.4

24.84

24.57

u/l

0.03

672

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

174

0.98

0.00

1.3

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

117

1.02

0.00

1.0

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

117

1.02

0.00

1.0

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

117

1.02

0.00

1.0

1.2

—

(40768800) Prostate Pathology biopsy report

117

1169

1.00

0.00

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

283

2823

1.00

0.00

1.4

1.5

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

270

1.00

0.00

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

665

1.01

0.00

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

420

1.00

0.00

3.5

2.3

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

225

1.02

0.00

1.2

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

408

1.00

0.00

1.9

1.4

85.93

81.72

umol/l

0.25

408

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

275

0.98

0.00

1.1

1.4

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

226

1.02

0.00

1.0

1.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

384

0.99

0.00

1.1

1.0

726.71

722.92

ng/l

0.02

260

(3028679) Herpes simplex virus Ab [Presence] in Serum

325

1.01

0.00

1.2

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

450

1.00

0.00

1.7

1.6

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

699

1.00

0.00

2.2

1.8

5893.33

1376.97

titre

—

(40760512) CD34 cells/100 cells in Bone marrow

0.00

0.0

1.5

—

(3017497) Pine Nut IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

0.03

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

0.0

1.0

—

0.43

—

(3036005) Urine sediment comments by Light microscopy Narrative

0.00

0.0

1.2

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

0.91

0.00

1.6

1.2

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

37.17

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

0.91

0.00

2.3

2.4

1.45

1.21

umol/l

—

(3038413) Eosinophils/100 leukocytes in Peritoneal dialysis fluid by Manual count

0.00

-0.00

0.0

8.2

—

15.00

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.3

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.00

-0.00

1.5

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.02

-0.00

1.0

1.2

12.20

15.80

u/l

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.96

-0.00

1.0

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

0.89

-0.00

1.0

1.2

—

21.50

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1.00

-0.00

1.6

1.4

—

14.54

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

0.00

-0.00

0.0

1.1

—

192.63

—

(3051101) Glucose [Moles/volume] in Cord blood

0.90

-0.00

3.4

7.0

—

(36303858) Crystals [Presence] in Urine

0.00

-0.00

0.0

1.0

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

0.95

-0.00

1.3

1.6

—

(3019529) Immunofixation for Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.90

-0.00

1.5

1.2

—

(3013931) Oligosaccharides [Presence] in Urine

0.00

-0.00

0.0

1.0

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

-0.00

0.0

1.1

—

1466.25

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.3

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.92

-0.00

1.5

1.0

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

0.95

-0.00

5.8

3.8

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.98

-0.00

1.0

1.1

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

(3038702) Sodium [Moles/volume] in Capillary blood

0.00

-0.00

0.0

5.0

—

138.50

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

-0.00

0.0

1.0

—

(3005067) clonazePAM [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

46.67

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

1.4

—

(3028717) Thiamine [Mass/volume] in Blood

0.98

-0.00

1.0

1.2

—

(3009179) Lactate [Moles/volume] in Peritoneal fluid

0.00

-0.00

0.0

1.0

—

1.82

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: AB1_VIRAL_HEMOR_FEVER_NOS_WIDE – Viral haemorrhagic fevers, not elsewhere classified/unspecified

GWS hits: 1

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Viral haemorrhagic fevers, not elsewhere classified/unspecified

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Viral haemorrhagic fevers, not elsewhere classified/unspecified (AB1_VIRAL_HEMOR_FEVER_NOS_WIDE)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints